Absorbent article, container for absorbent article, and sheet for absorbent article

The absorbent article's top sheet facilitates the permeation of vaginal discharge with a viscosity of 15 to 30 Pa·s to the inspection member, addressing the challenges of small volume and high viscosity, enabling effective health condition assessment.

WO2024242118A1PCT designated stage expired Publication Date: 2024-11-28UNI CHARM CORP
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/018737
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-11-02
Filing Date
2024-05-21
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing absorbent articles face challenges in effectively inspecting health conditions based on vaginal discharge due to its small amount and high viscosity, which makes it difficult for the discharge to reach the test member, resulting in inadequate test results.

Method used

An absorbent article with a top sheet that allows 6% or more of an artificial body fluid with a viscosity of 15 to 30 Pa·s to permeate from the skin-side surface to the non-skin-side surface, ensuring that vaginal discharge, which has a similar viscosity, can pass through and be directed to the inspection member for accurate health condition assessment.

Benefits of technology

This design enables a high proportion of vaginal discharge to be guided to the inspection member, allowing for proper health condition inspection, even when the discharge has higher viscosity than urine or menstrual blood, thereby improving the accuracy of health assessments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024018737_28112024_PF_FP_ABST
    Figure JP2024018737_28112024_PF_FP_ABST
Patent Text Reader

Abstract

The purpose of the present invention is to properly examine the state of a wearer's health from vaginal discharge. An absorbent article (1) comprises an examination member (60) for examining the state of a wearer's health from vaginal discharge The present invention has a top sheet (11) that is disposed closer to the skin than the inspection member is and that comes into contact with the skin surface of the wearer. The top sheet allows at least 6% of artificial body fluid which is in contact with the skin side surface of the top sheet and has a viscosity of 15-30 Pa•s at 23°C to pass through onto the non-skin side surface of the top sheet. An absorbent article sheet constitutes the skin-side surface of the absorbent article and is in contact with the skin surface of the wearer. The absorbent article sheet allows at least 6% of an artificial body fluid which is in contact with the skin side surface of the sheet and has a viscosity of 15-30 Pa•s at 23°C to pass through onto the non-skin side surface of the sheet.
Need to check novelty before this filing date? Find Prior Art

Description

Absorbent article, container for absorbent article, and sheet for absorbent article

[0001] The present invention relates to an absorbent article provided with a test member for testing the health condition of a wearer from vaginal discharge, and a sheet for an absorbent article used in the absorbent article.

[0002] Patent Document 1 discloses an absorbent article equipped with a testing member for testing the health condition of a wearer from vaginal discharge. Patent Document 1 discloses that the pH of vaginal discharge, among other excrement, fluctuates depending on changes in physical condition such as the menstrual cycle, infections such as trichomoniasis, menopause, and water rupture during pregnancy, and that the health condition and physical condition can be determined by measuring the changes in pH.

[0003] Japanese Patent Application Laid-Open No. 2000-279442

[0004] As described above, vaginal discharge is a suitable target for testing health status among excrement, but the amount excreted is small, making it difficult to detect.Furthermore, vaginal discharge has a high viscosity among excrement, making it difficult for it to reach the testing element, making it difficult to obtain appropriate test results.

[0005] The present invention has been made in view of such problems, and has as its object to appropriately examine the health condition of a wearer from vaginal discharge.

[0006] An absorbent article according to one embodiment includes a test element for testing the health condition of a wearer based on vaginal discharge. The absorbent article further includes a top sheet that is positioned closer to the skin than the test element and contacts the wearer's skin. The top sheet allows at least 6% of an artificial body fluid that has a viscosity of 15 to 30 Pa·s at 23°C and is in contact with the skin surface of the top sheet to pass through to the non-skin surface of the top sheet.

[0007] According to one embodiment, an absorbent article container includes an absorbent article and a container body that contains the absorbent article. The container body has a design portion visible from the outer surface of the container. The design portion has a pressure indicator that indicates a state in which the outer surface of the worn article is pressed toward the wearer to bring the skin-facing surface of the top sheet of the absorbent article into contact with the wearer's skin.

[0008] A sheet for absorbent articles according to one embodiment constitutes the skin-side surface of an absorbent article and contacts the skin of a wearer. The sheet for absorbent articles allows 6% or more of an artificial body fluid having a viscosity of 15 to 30 Pa·s at 23°C that is in contact with the skin-side surface of the sheet to pass through to the non-skin-side surface of the sheet.

[0009] FIG. 1 is a plan view of an absorbent article according to an embodiment, as seen from the skin side. FIG. 2 is a plan view of an absorbent article according to an embodiment, as seen from the non-skin side. FIG. 3 is a cross-sectional view taken along line A-A in FIG. 1. FIG. 4 is a cross-sectional view taken along line B-B in FIG. 1. FIG. 5 is a cross-sectional view taken along line C-C in FIG. 1. FIG. 6 is an enlarged view of portion D in FIG. 5. FIG. 7 is a cross-sectional photograph of a cross-section taken along the width direction of a test member. FIG. 8 is a cross-sectional view of a test member taken along the width direction. FIG. 9 is a diagram for explaining the coloration of the test member. FIG. 10 is a schematic diagram showing a cross-section taken along the width direction of a worn article having an absorbent article attached thereto. FIG. 11 is a front view of a container according to a first embodiment. FIG. 12 is a back view of a container according to the first embodiment. FIG. 13 is a diagram showing a container according to a second embodiment. FIG. 14 is a diagram for explaining an artificial body fluid permeation test.

[0010] (1) Overview of the Embodiments The present specification and accompanying drawings make at least the following clear. The invention according to Aspect 1 is an absorbent article. The absorbent article includes a test element for testing a wearer's health condition from vaginal discharge. The absorbent article includes a top sheet positioned closer to the skin than the test element and in contact with the wearer's skin. The top sheet allows at least 6% of an artificial body fluid having a viscosity of 15 to 30 Pa·s at 23°C that is in contact with the skin-side surface of the top sheet to pass through to the non-skin-side surface of the top sheet. As a result of extensive research by the applicant, it has been found that the viscosity of typical vaginal discharge is 15 to 30 Pa·s. The top sheet allows a high proportion of artificial body fluid, having a viscosity similar to that of vaginal discharge, to pass through from the skin-side surface of the top sheet to the non-skin-side surface of the top sheet at a rate of at least 6%. Therefore, even vaginal discharge, which has a higher viscosity than urine and menstrual blood, can pass through the top sheet and be guided to the test element. Although vaginal discharge is excreted in small amounts compared to urine and menstrual blood, a high proportion of vaginal discharge can pass through the top sheet and be guided to the testing member, making it possible to properly test the wearer's health condition from the vaginal discharge.

[0011] According to a preferred aspect, the invention according to Aspect 2 may be the invention according to Aspect 1, and may have the following features: When the skin-side surface of the top sheet is pressed toward the wearer with a pressure of 1.60 to 1.70 kPa, the top sheet allows 6% or more of the artificial body fluid that comes into contact with the skin-side surface of the top sheet to pass through to the non-skin-side surface of the top sheet. When worn, absorbent articles are subjected to various forces. As a result of extensive research by the applicant, it has been found that in various situations, such as when the wearer changes position or when the wearer pulls up a worn article with the absorbent article fastened to the inner surface, the skin-side surface of the top sheet is pressed toward the wearer with a pressure of at least 1.60 to 1.70 kPa. In this case, since 6% or more of the artificial body fluid that comes into contact with the skin-side surface of the top sheet passes through to the non-skin-side surface of the top sheet, vaginal discharge that has passed through the top sheet can be guided to the testing member, making it possible to appropriately test the wearer's health condition from the vaginal discharge.

[0012] According to a preferred aspect, the invention according to Aspect 3 may have the following features in the invention according to Aspect 2. The absorbent article is an absorbent article fastened to the inner surface of a worn article, and the pressed state is a state in which the outer surface of the worn article is pressed toward the wearer so that the skin-side surface of the top sheet of the absorbent article abuts against the wearer's skin. Panty liners, unlike sanitary napkins, absorb a small amount of body waste and are not used for a specific period like sanitary napkins but are used daily. Therefore, unlike sanitary napkins, which are used with sanitary shorts, panty liners are attached to underwear used daily. Therefore, panty liners do not adhere closely to the wearer via underwear, and gaps are likely to form between the panty liners and the wearer's body. In such a usage mode, the wearer can intentionally press the outer surface of the worn article toward the wearer so that the skin-side surface of the top sheet of the absorbent article abuts against the wearer's skin in order to perform an inspection using an inspection member. This pressure by the wearer is generally achieved by pressing with a finger so as to fill the gap between the skin-facing surface of the top sheet of the absorbent article and the skin-facing surface of the wearer, so as not to apply excessive force to the delicate genital area. As a result of extensive research by the applicant, when the wearer presses the outer surface of the worn article toward the wearer with their finger, the top sheet is pressed toward the wearer with a pressure of at least 1.60 to 1.70 kPa. In this pressed state, vaginal discharge that has passed through the top sheet can be guided toward the testing member, making it possible to appropriately test the wearer's health condition from the vaginal discharge.

[0013] According to a preferred aspect, the invention according to Aspect 4 may have the following feature in the invention according to any one of Aspects 1 to 3: the top sheet and the test member are in contact with each other. According to this aspect, vaginal discharge can be directly guided to the test member via the top sheet, and the excrement can be quickly and reliably guided to the test member.

[0014] According to a preferred aspect, the invention according to Aspect 5 may have the following feature in the invention according to any one of Aspects 1 to 4: The length in the width direction of the inspection member is shorter than the width of a woman's finger. According to this aspect, when a finger is placed on the wearing article along the front-to-rear direction of the absorbent article and pressed against it, the finger can press against the entire width direction of the inspection member.

[0015] According to a preferred aspect, the invention according to Aspect 6 may have the following features in the inventions according to Aspects 1 to 5: A non-skin-side cover sheet is provided that covers the non-skin-side of the test member. The length of the non-skin-side cover sheet in the width direction is shorter than the width of a woman's finger. According to this aspect, when a finger is placed on the worn article along the front-to-back direction of the absorbent article and pressed against it, the finger can press against the entire width of the test member with the finger via the non-skin-side cover sheet.

[0016] According to a preferred aspect, the invention according to Aspect 7 may have the following features in the invention according to any one of Aspects 1 to 6: The top sheet is composed of a sheet having fibers. The average inter-fiber distance of the top sheet is longer than the average diameter of women's pubic hair. According to this aspect, because the average inter-fiber distance of the top sheet is longer than the average diameter of women's pubic hair, pubic hair becomes more likely to penetrate into the top sheet when the top sheet comes into contact with the wearer's skin. Vaginal discharge adhering to pubic hair becomes more likely to transfer to the top sheet.

[0017] According to a preferred aspect, the invention according to Aspect 8 may be the invention according to any one of Aspects 1 to 7, and have the following features: The test member has a contact portion that comes into contact with the excrement. The contact portion and the top sheet are made of a sheet having fibers. The average inter-fiber distance of the top sheet is longer than the average inter-fiber distance of the contact portion. According to this aspect, excrement in the top sheet is more likely to migrate to the contact portion, where the average inter-fiber distance is shorter, making it easier for even a small amount of vaginal discharge to reach the test member.

[0018] According to a preferred aspect, the invention according to aspect 9 may have the following features in the invention according to any one of aspects 1 to 8. The absorbent article has at least a compressed area where compressed sections are formed by compressing the top sheet in the thickness direction, and a non-compressed area where no compressed sections are formed. The test member has a contact section that comes into contact with bodily waste. The contact section is in contact with the top sheet in the non-compressed area. The test member is likely to come into surface contact with the contact section. According to this aspect, bodily waste in the top sheet is more likely to migrate to the contact section, making it easier for even a small amount of vaginal discharge to reach the test member.

[0019] According to a preferred aspect, the invention according to Aspect 10 may be the invention according to any one of Aspects 1 to 9, and have the following features: The test member has a contact portion that comes into contact with excrement and a transfer portion having labeled antibodies that undergo an antigen-antibody reaction with excrement components that are components contained in excrement. The average thickness of the top sheet in the region covering the contact portion is thicker than the average thickness of the top sheet in the region covering the transfer portion. According to this aspect, the top sheet covering the contact portion has a thick average thickness, and a large volume of space can be secured for holding excrement. Therefore, the top sheet in the region covering the contact portion draws in a larger amount of excrement, making it easier for the excrement to transfer from the top sheet to the contact portion.

[0020] According to a preferred aspect, the invention according to Aspect 11 may be the invention according to any one of Aspects 1 to 10, and may have the following features. The test member has five equal regions obtained by dividing the test member into five equal regions in the width direction, with a center region located in the center of the width direction and side regions located at both ends of the test member in the width direction. The top sheet covers the entire skin surface of the test member. The average thickness of the top sheet in the region covering the side regions is thicker than the average thickness of the top sheet in the region covering the center region. According to this aspect, the average thickness of the top sheet covering the center region is thin, so that excrement can be quickly guided from the top sheet side to the test member without being continuously retained in the top sheet. Therefore, a color reaction is more likely to occur in the indicator in the center region. By showing a color reaction in the center of the width direction of the test member, the color reaction is more easily visible to the wearer, improving the visibility of the test results.

[0021] According to a preferred aspect, the invention according to Aspect 12 may have the following features in the invention according to any one of Aspects 1 to 11: A non-skin-side cover sheet covering the non-skin side of the test member is provided. The non-skin-side cover sheet is liquid-impermeable and covers the entire width of the test member. According to this aspect, by covering the non-skin side of the test member over the entire width of the test member with a liquid-impermeable sheet, excrement that reaches the test member is prevented from penetrating to the non-skin side of the test member, making it easier for the excrement to move within the test member.

[0022] According to a preferred aspect, the invention according to Aspect 13 may have the following feature in the invention according to any one of Aspects 1 to 12: The contact angle of the artificial body fluid with the top sheet is smaller than the contact angle of the artificial body fluid with the wearer's skin. According to this aspect, vaginal discharge is more likely to migrate toward the top sheet than toward the skin, making it easier for vaginal discharge adhering to the skin to be drawn toward the top sheet.

[0023] According to a preferred aspect, the invention according to Aspect 14 may be the invention according to any one of Aspects 1 to 13, and may have the following features: The test element is a test element using immunochromatography to detect luteinizing hormone from vaginal discharge. The immunochromatographic test element forms a complex with a fecal component, which is a component contained in the feces, through an antigen-antibody reaction, and the complex develops color with an indicator at the destination where it migrates, thereby indicating the test result. Therefore, a larger amount of feces is required than in a test using test paper. However, according to the present invention, even a small amount of vaginal discharge can be guided to the test element, making it possible to perform a test using immunochromatography.

[0024] Aspect 15 of the invention relates to an absorbent article container. The absorbent article container includes an absorbent article and a container that contains the absorbent article. The container body has a design portion visible from the outer surface of the container. The design portion has a pressing indicator portion that indicates a state in which the outer surface of the worn article is pressed toward the wearer to bring the skin-side surface of the top sheet of the absorbent article into contact with the wearer's skin. According to this aspect, by visually checking the pressing indicator portion, the wearer can understand that the outer surface of the worn article has been pressed toward the wearer to bring the skin-side surface of the top sheet of the absorbent article into contact with the wearer's skin, making it easier to perform the pressing state. By performing the pressing state, the wearer can more easily guide vaginal discharge to the test element, and appropriate test results can be obtained based on the vaginal discharge.

[0025] A sixteenth aspect of the invention relates to a sheet for absorbent articles. The sheet for absorbent articles constitutes the skin-facing surface of an absorbent article and contacts the skin of a wearer. The sheet for absorbent articles allows at least 6% of an artificial body fluid having a viscosity of 15 to 30 Pa·s at 23°C in contact with the skin-facing surface of the sheet for absorbent articles to permeate to the non-skin-facing surface of the sheet for absorbent articles. The sheet for absorbent articles of this aspect allows a high proportion of artificial body fluid of a predetermined viscosity in contact with the skin-facing surface to permeate to the non-skin-facing surface of the sheet, at least 6%. Therefore, even vaginal discharge, which has a higher viscosity than urine and menstrual blood, can permeate the sheet. In particular, by using the sheet for absorbent articles on the skin-facing side of a test member, a high proportion of vaginal discharge can be permeated through the sheet and guided to the test member, making it possible to appropriately test the wearer's health condition from the vaginal discharge.

[0026] (2) Absorbent Article According to an Embodiment Hereinafter, an embodiment of the present invention will be described with reference to the drawings. Note that in the following description of the drawings, identical or similar parts are designated by identical or similar reference numerals. However, it should be noted that the drawings are schematic, and the dimensional ratios and the like may differ from those of the actual product. Therefore, specific dimensions and the like should be determined with reference to the following description. Furthermore, parts in which the dimensional relationships and ratios differ between the drawings may be included. Furthermore, in the cross-sectional views, for the sake of convenience, the components are shown separated, but in the actual product, the components are in contact with each other. The absorbent article 1 is a panty liner. The absorbent article 1 is used by being attached to a wearable article such as underwear.

[0027] FIG. 1 is a plan view of the absorbent article 1 as viewed from the skin side T1. FIG. 2 is a plan view of the absorbent article 1 as viewed from the non-skin side T2. FIG. 3 is a cross-sectional view taken along line A-A in FIG. 1. FIG. 4 is a cross-sectional view taken along line B-B in FIG. 1. FIG. 5 is a cross-sectional view taken along line C-C in FIG. 1. FIG. 6 is an enlarged view of portion D in FIG. 5. The absorbent article 1 may have a front-to-rear direction L, a width direction W, and a thickness direction T. The front-to-rear direction L is the direction extending from the front side (belly side) of the wearer to the back side (dorsal side) of the wearer, or the direction extending from the back side of the wearer to the front side. The width direction W is a direction perpendicular to the front-to-rear direction L. The thickness direction T is a direction perpendicular to the front-to-rear direction L and the width direction W. The thickness direction T extends between the skin side T1 and the non-skin side T2. The skin side T1 corresponds to the side that faces the wearer's skin during use. The non-skin side T2 corresponds to the side opposite the skin side, i.e., the side facing away from the wearer's skin, during use.

[0028] The absorbent article 1 has front regions S1, rear regions S2, and a crotch region S3. The crotch region S3 is a region positioned opposite the wearer's excretory opening, for example, the vaginal opening. When the absorbent article 1 is attached to a worn article, the crotch region S3 is positioned under the crotch of the worn article and between the wearer's legs. The front region S1 is located forward of the crotch region S3. The front edge of the front region S1 defines the front edge of the absorbent article 1. The rear region S2 is located rearward of the crotch region S3. The rear edge of the rear region S2 defines the rear edge of the absorbent article 1. The crotch region S3 may be a central region among three equal regions obtained by dividing the absorbent article 1 in the front-to-rear direction. In an absorbent article having wings, the crotch region S3 may be the region where the wings are provided.

[0029] In the present invention, the outer portion refers to a portion occupying a certain range in the width direction W, including the outer edge in the width direction W, and the outer edge refers to the outer edge in the width direction W. The outer edge of a component occupying a certain range in the front-to-rear direction is an edge connecting points located on the outer side in the width direction of the component, over the entire component. In the present invention, the inner portion refers to a portion occupying a certain range in the width direction W, including the inner edge in the width direction W, and the inner edge refers to the inner edge in the width direction W. The inner edge of a component occupying a certain range in the front-to-rear direction is an edge connecting points located on the inner side in the width direction of the component, over the entire component. In the present invention, the front end and rear end refer to portions occupying a certain range in the front-to-rear direction L, including edges in the front-to-rear direction L, and the front edge and rear edge are edges in the front-to-rear direction L. The outer end refers to the front end and rear end, and the outer edge refers to the front edge and rear edge. In addition, the inner side refers to a side that includes the inner side edge and extends along the front-to-rear direction L. The outer side is a side that includes the outer edge and extends along the front-to-rear direction L. In this specification, the term "along the front-to-rear direction L" means a direction that has an angle of less than 45° with respect to the front-to-rear direction L, and the term "along the width direction W" means a direction that has an angle of less than 45° with respect to the width direction W.

[0030] The absorbent article 1 may have at least an absorbent core 31, a top sheet 11, and a back sheet 21. The absorbent article 1 may have a vertically elongated shape. The absorbent core 31 contains an absorbent material that absorbs liquid. The absorbent material may be composed of, for example, at least one of pulp and a superabsorbent polymer. The absorbent core 31 may be composed of an air-laid pulp sheet. The absorbent core 31 may be sandwiched in the thickness direction by core wrap sheets.

[0031] The top sheet 11 constitutes the skin-facing surface of the absorbent article 1 and contacts the wearer's skin. The top sheet 11 may be made of, for example, a spunlace nonwoven fabric, an air-through nonwoven fabric, a spunbond nonwoven fabric, or an SMS nonwoven fabric. The visible light transmittance of the top sheet 11 may be 60% or more. The visible light transmittance of the top sheet 11 may be preferably 70% or more, and more preferably 80% or more. The basis weight of the top sheet 11 is 90 g / m 2 It may be less than 30 g / m 2 It may be 17 g / m or less. 2 The thickness of the top sheet 11 may be 5 mm or less. The configuration of the top sheet 11 will be described in detail later.

[0032] The visible light transmittance can be measured using, for example, a spectrophotometer (JASCO Corporation V-570). Specifically, the visible light transmittance can be measured using a measurement target cut to 30 mm x 30 mm. In the following, the wavelength range of visible light is assumed to be 380 nm to 750 nm. The measurement conditions may be as follows: Photometry mode: Abs Response: Medium Bandwidth: 2.0 nm Near infrared: 8.0 nm Scanning speed: 1000 nm / min Start wavelength: 830 nm End wavelength: 350 nm Data acquisition interval: 1.0 nm

[0033] The backsheet 21 constitutes the non-skin side T2 of the absorbent article 1. In the absorbent article 1 to be attached to a worn article, the backsheet 21 abuts against the worn article. The backsheet 21 may be made of, for example, a liquid-impermeable film, or a liquid-impermeable and breathable sheet. An example of a liquid-impermeable and breathable sheet is a film made of polyethylene resin and calcium carbonate, with fine interconnecting pores on the surface that allow water vapor and air to pass through while blocking water. The non-skin side of the backsheet 21 may be provided with fastening parts 25 for joining the absorbent article 1 to a worn article (such as underwear). The fastening parts 25 may be provided with an adhesive such as a hot-melt adhesive, or with an engaging member such as a mechanical fastener. The fastening parts 25 may extend in the width direction W and be arranged at intervals in the front-to-rear direction L.

[0034] The absorbent article 1 may have an auxiliary sheet 15 arranged on the skin side T1 of the absorbent core 31. The auxiliary sheet 15 improves the ability to draw bodily fluids from the top sheet 11 into the absorbent core 31. The auxiliary sheet 15 may be made of an air-through nonwoven fabric. The auxiliary sheet may be arranged on the non-skin side T2 of the test member 60 and on the skin side T1 of the absorbent core 31.

[0035] The absorbent article 1 may have compressed regions where compressed sections 35 are formed by compressing at least the top sheet 11 in the thickness direction T, and non-compressed regions where no compressed sections 35 are formed. The compressed regions are regions where the compressed sections 35 are arranged in the plan view shown in Figure 1, and the non-compressed regions are regions where no compressed sections are arranged in the plan view. The compressed sections 35 need only compress at least the top sheet 11, and may compress the top sheet 11 and the auxiliary sheet 15, or may compress the top sheet 11 and the absorbent core 31. The compressed sections 35 in this embodiment are formed by compressing the top sheet 11 and the auxiliary sheet 15. The compressed sections 35 may be arranged on both sides of the center of the absorbent article 1 in the width direction W.

[0036] The absorbent article 1 has a test member 60 that tests the wearer's health condition. The test member 60 indicates the wearer's health condition by changing color (changing color) based on excrement. The test member 60 may be made of any material, such as paper, nonwoven fabric, or woven fabric, as long as it has a material that can hold or contain an indicator. Examples of excrement (specimens) include blood (menstrual blood), urine, feces, sweat, and vaginal discharge. Examples of items that indicate the health condition include physical condition-related items (pH, iron deficiency anemia, renal function, myocardial infarction, inflammation / infection, nutritional status evaluation, etc.), pregnancy-related items (menstrual cycle prediction, ovulation prediction, etc.), and mental health-related items (depression tendency, medication, etc.). Examples of detection targets include urinary waste products (urine specific gravity), white blood cells, hydrogen ions (pH), proteins, glucose, ketone bodies, urobilinogen, bilirubin, urinary occult blood, nitrite, steroids, peptides, aromatic compounds, FSH (follicle-stimulating hormone), BUN (urea nitrogen), AlB (albumin), LPS (lipopolysaccharide), hCG (human chorionic gonadotropin), LH (luteinizing hormone), U-ALB, CRP (C-reactive protein), myoglobin, CK-MB, troponin I, troponin T, hemoglobin, strep A, HBs antibody, HIV antibody, TP antibody, rotavirus, influenza virus, adenovirus, DNA, O-157, cocaine, marijuana, morphine, ferritin, and IgA (immunoglobulin A). The detection target is a chemical substance (inorganic or organic) determined according to an item indicating the health condition, and reacts with other chemical substances to cause coloration. The test member 60 can use, for example, immunochromatography or a test paper method to test the health condition.

[0037] The test element 60 of this embodiment is a test element using immunochromatography to detect luteinizing hormone (LH) in vaginal discharge. The test element 60 may detect luteinizing hormone levels of 0.05 mIU / mL to 10.0 mIU / mL as positive. Unlike conventional urinary luteinizing hormone (LH) test kits, the absorbent article 1 is an everyday item, making it extremely easy to predict the day of ovulation and lessening psychological resistance. Furthermore, while conventional ovulation prediction methods using urine require procedures such as applying urine to a test strip and can take a relatively long time (e.g., 10 minutes), the absorbent article 1 allows a detection reaction to occur simply by wearing the absorbent article 1, accompanying the discharge of vaginal discharge, making ovulation prediction easier. For example, the absorbent article 1 allows the detection results to be checked more easily, for example, when the wearer goes to the toilet, rather than waiting 10 minutes to check the test results. Furthermore, unlike conventional methods that use urine, the absorbent article of the present invention has the advantage that detection can be performed without worrying about staining the hands. Therefore, it is possible to provide an absorbent article that enables simple prediction of the day of ovulation.

[0038] In addition, as a result of the applicant's extensive research, luteinizing hormone (LH) detected from vaginal discharge can predict ovulation from five days before to the day of ovulation itself. In contrast, luteinizing hormone (LH) detected from urine can predict ovulation from two days before ovulation itself. More specifically, test elements for detecting LH from urine are generally known to detect luteinizing hormone levels of 20.0 mIU / mL to 100.0 mIU / mL as positive. That is, since the range of LH levels in urine is broader than that in vaginal discharge, test elements for detecting LH from urine must maintain lower sensitivity than test elements for detecting LH in vaginal discharge in order to eliminate noise. Test elements for detecting LH in urine may pick up peaks other than the fertile window, making it difficult to design the sensitivity of the test device to fall within the same range as vaginal discharge. Therefore, test elements for detecting LH in urine have difficulty predicting ovulation more than two days before ovulation. In contrast, a test element that detects luteinizing hormone (LH) from vaginal discharge can determine the predicted date between five days and three days before ovulation. Therefore, a test element that detects luteinizing hormone (LH) from vaginal discharge can determine the predicted date between five days and three days before ovulation. Being able to determine between five days and three days before ovulation allows for planning and scheduling pregnancy attempts. Compared to previous methods that could determine the date on or the day before ovulation, this method reduces the burden of having to plan pregnancy attempts on the day itself, and prevents pregnancy attempts from being canceled due to an inability to plan in advance, thereby reducing mental burden and improving the feasibility of pregnancy attempts. Furthermore, predictions of ovulation based on the menstrual cycle can only be determined approximately two weeks before ovulation. Considering individual differences, predicting with a two-week gap may result in low accuracy. Furthermore, two weeks is too long from the perspective of planning. In contrast, a test device that detects luteinizing hormone (LH) from vaginal discharge can identify the predicted date between 3 and 5 days before ovulation, making it possible to predict the ovulation date close to the ovulation date, thereby improving the accuracy of ovulation date predictions and increasing the feasibility of pregnancy attempts.

[0039] As shown in FIG. 6 , the test member 60 may include a transfer unit 66 that transfers excrement components contained in excrement and guides them to the display unit 62, and the display unit 62 changes color based on the excrement components guided from the transfer unit 66. The display unit 62 displays the wearer's health condition. The display unit 62 may display the wearer's health condition based on the color after coloring, or the presence or absence of coloring. The wearer can confirm their health condition by visually determining the color after coloring and / or the presence or absence of coloring. The display unit 62 may include an indicator that changes color based on at least one of the excrement components and the labeled antibody. The indicator may include a chemical substance (inorganic or organic) that changes color upon reacting with a target substance contained in excrement or a substance derived from the target substance (e.g., a complex formed by an antigen-antibody reaction between the target substance and an antibody). The indicator may also contain a chemical substance (inorganic or organic) that develops color by reacting with a labeled antibody (a chemical substance that undergoes an antigen-antibody reaction with the detection target) that has migrated with the excrement.

[0040] The test member 60 may have a contact portion 64 that comes into contact with the excrement. The contact portion 64 may be configured, for example, as a pad (which may be referred to as a sample pad or specimen pad). The contact portion 64 may be configured to draw in the excrement and guide the excrement components required for testing to the transfer portion 66. The display portion 62 may be configured with multiple display portions with different detection targets. The display portion 62 may have, for example, a first display portion 62A and a second display portion 62B. The first display portion 62A is located closer to the contact portion 64 than the second display portion 62B.

[0041] The excrement components may move in the movement section 66 by capillary action. The excrement components may include the detection target. The movement section 66 may have a display movement section 66A through which the excrement components move from the contact section 64 to the display section 62, and a terminal movement section 66B through which the excrement components move in a direction away from the display section 62. The display movement section 66A may have a first display movement section 66A1 from the contact section 64 to the first display section 62A, and a second display movement section 66A2 through which the excrement components move between the plurality of display sections 62 (in the embodiment, from the first display section 62A to the second display section 62B). The terminal movement section 66B is a section through which the excrement components, etc. that have passed through the display section 62 move.

[0042] For example, immunochromatography can be used to test health conditions. In immunochromatography, the contact section 64 that contacts the excrement may be configured as a sample pad or a specimen pad. Excrement components that contact the contact section 64 move through the display movement section 66A. Specifically, the excrement components move to the display section 62 in the first display movement section 66A1. The display section 62 contains an antibody (labeled antibody) that reacts with the detection target (antigen). The labeled antibody may be included in the first display movement section 66A1. The portion of the first display movement section 66A1 that contains the labeled antibody may be configured as, for example, a conjugate pad. In the first display movement section 66A1, the excrement components, complexes formed by an antigen-antibody reaction with the detection target contained in the excrement components, and the labeled antibody may move by capillary action. The portion through which these chemical substances move may be configured as, for example, a membrane. The migration section 66 of this embodiment has a conjugate pad 66X and a membrane 66Y, and the labeled antibody is contained in the conjugate pad 66X.

[0043] The display section 62 is a region containing an indicator (capture antibody). The first display section 62A may contain a capture antibody that captures (binds to) the complex. The first display section 62A changes color when the complex is captured by the capture antibody. The first display section 62A may be referred to as a test line. The complex, labeled antibody, and excrement components not captured by the first display section may travel through the second display movement section 66A2 and reach the second display section 62B from the first display section 62A.

[0044] The second indicator 62B may contain a capture antibody different from that of the first indicator 62A. The capture antibody of the second indicator 62B may capture a complex different from the complex captured by the first indicator 62A, or may capture a labeled antibody. The second indicator 62B changes color when the complex or labeled antibody is captured by a capture antibody different from that of the first indicator 62A. The second indicator 62B, which captures the labeled antibody, may be referred to as a control line and serves as an indication for determining whether the test has been completed correctly. The excrement components that have passed through the indicator 62 (i.e., components not captured by the capture antibody) move through the terminal migration section 66B. The terminal migration section 66B may be composed of a membrane 66Y. The test member 60 may also have an absorbent section 67 that absorbs excrement components that have passed through the indicator 62. Instead of the absorbent section 67, the excrement components that have passed through the indicator 62 may be absorbed by the absorbent core 31. When the immunochromatography method is used, the display unit 62 and the contact unit 64 are disposed at different positions.

[0045] The inspection member 60 has a first direction, which is the movement direction of excrement components from the moving section 66 to the display section 62, and a second direction perpendicular to the first direction. The first direction is a direction extending in the movement direction of excrement components, and in this embodiment, is a direction along the front-to-back direction L of the absorbent article 1. That is, in this embodiment, the first direction is the front-to-back direction L, and the second direction is the width direction W. However, in a modified example, the first direction may be the width direction W, and the second direction may be the front-to-back direction L. The length of the inspection member 60 in the first direction may be longer than the length in the second direction.

[0046] The length of the test member 60 along the width direction W may be 1 mm or more and 10 mm or less. Although there are individual differences, the width of the labia minora, etc. is typically around 10 mm. By making the length of the test member along the width direction W shorter than the width of the labia minora, etc., discomfort during wear can be reduced. From the standpoints of visibility to the wearer and processability, the length of the test member 60 along the width direction W may preferably be 2 mm or more. Preferably, the length of the test member along the width direction W may be 3 mm or less. By making the length of the test member along the width direction W 3 mm or less, the amount of liquid that needs to be retained for detection is relatively reduced. Therefore, LH can be detected satisfactorily even when detecting vaginal discharge that is small in volume, highly viscous, and has a low LH content.

[0047] Next, the configuration of a preferred test member will be described in detail. FIG. 7 is a photograph of a cross section of the test member 60 taken along the width direction W. FIG. 7 shows a cross section of the region where the membrane 66Y is disposed. FIG. 8 is a schematic diagram of a cross section of the test member 60 taken along the width direction W. FIG. 8(A) is a cross section taken along line F-F in FIG. 6, FIG. 8(B) is a cross section taken along line G-G in FIG. 6, and FIG. 8(C) is a cross section taken along line H-H in FIG. Note that the cross section in FIG. 8 is a schematic diagram, and the actual skin-side surface of the test member 60 may have a smoothly sloping curve, as shown in FIG. 7. More specifically, the skin-side surface of the test member 60 may have a curved shape that slopes from the outer edge 60E of the test member toward the inside in the width direction, from the non-skin side T2 toward the skin side T1, and the average thickness of a certain range of side regions extending from the outer edge 60E toward the inside in the width direction of the test member may be thinner than the average thickness of the center region. The test member 60 of this embodiment has a sample pad 64Z as the contact portion 64, and a conjugate pad 66X and a membrane 66Y as the moving portion 66. The sample pad 64Z is disposed at one end (the rear end in this embodiment) in the front-to-rear direction of the test member 60. The conjugate pad 66X is disposed on the non-skin side T2 of the sample pad 64Z. The conjugate pad 66X overlaps the other end (the front end in this embodiment) of the sample pad 64Z in the thickness direction in the front-to-rear direction L of the sample pad 64Z in the thickness direction, but does not overlap one end of the sample pad 64Z in the thickness direction T. Therefore, excrement drawn into the sample pad 64Z passes through the sample pad 64Z and is then guided to the conjugate pad 66X. The membrane 66Y is disposed on the non-skin side T2 of the conjugate pad 66X. The membrane 66Y overlaps the other end of the conjugate pad 66X in the thickness direction T, but does not overlap one end of the conjugate pad 66X in the thickness direction. One end of the membrane 66Y and the other end of the sample pad 64Z are spaced apart in the front-to-rear direction L. Therefore, excrement components move in the order of the sample pad 64Z, conjugate pad 66X, and membrane 66Y. A first display portion 62A and a second display portion 62B are provided on the skin side T1 surface of the membrane 66Y.The first display section 62A and the second display section 62B are arranged with an interval therebetween in the front-rear direction L.

[0048] The test member 60 of this embodiment includes a test skin-side sheet 68, a non-test skin-side sheet 69, and an absorbent portion 67. The test skin-side sheet 68 is made of a liquid-impermeable film. The test skin-side sheet 68 constitutes the skin side T1 of the test member 60 and is positioned closer to the skin side T1 than the sample pad 64Z, conjugate pad 66X, membrane 66Y, absorbent portion 67, and non-test skin-side sheet 69. The test skin-side sheet 68 does not cover the skin side T1 of a portion of the sample pad 64Z (the area of ​​the sample pad 64Z not covered by the conjugate pad 66X), but covers the skin side T1 over the entire area of ​​the sample pad 64Z covered by the conjugate pad 66X, the conjugate pad 66X, the membrane 66Y, and the absorbent portion 67. The non-skin test sheet 69 constitutes the non-skin side T2 surface of the test member 60 and is positioned closer to the skin than the sample pad 64Z, conjugate pad 66X, membrane 66Y, absorbent portion 67, and test skin side sheet 68. The non-skin test sheet 69 covers the entire non-skin side T2 of the sample pad 64Z, conjugate pad 66X, membrane 66Y, absorbent portion 67, and test skin side sheet 68. The absorbent portion 67 overlaps the other end of the membrane 66Y in the front-to-rear direction L in the thickness direction T, but does not overlap one end of the membrane 66Y in the thickness direction T. The absorbent portion 67 is positioned closer to the skin side T1 than the membrane 66Y.

[0049] The labeled antibody of the test member 60 may have a colored antibody bound to a molecule that contributes to coloration. The labeled antibody may consist solely of the colored antibody, or may include antibodies other than the colored antibody. The colored antibody is colored before color development. The colored antibody may be colored a different color from the component on which the colored antibody is disposed (e.g., the conjugate pad). Examples of the colored antibody include blue, red, yellow, and white. In a plan view of the absorbent article 1, the color difference between the portion on which the colored antibody is disposed and the surrounding area of ​​the colored antibody (in this embodiment, the portion of the conjugate pad on which the colored antibody is not disposed) may be 3.0 or more. In this embodiment, the portion on which the colored antibody is disposed is the conjugate pad 66X. The complex formed by the antigen-antibody reaction of the colored antibody is colored based on the colored antibody.

[0050] FIG. 9 shows an example of the coloring pattern of the indicator 62 in a plan view of the test member 60 as viewed from the skin side T1. In FIG. 9, the area colored by the colored antibody is indicated by R1, and the colored area described below is indicated by R20. FIG. 9(A) shows the test member 60 before both the first indicator 62A and the second indicator 62B show a color reaction (hereinafter, "before coloring"). FIG. 9(B) shows the test member 60 in the test state. FIG. 9(C) shows the absorbent article 1 after both the first indicator 62A and the second indicator 62B show a color reaction (hereinafter, "after coloring"). FIG. 9(C) shows the coloring pattern when the target substance is detected (when the test line shows a color). In the pre-coloring state shown in FIG. 9(A), the first indicator 62A and the second indicator 62B are integrated with their surroundings. The state in which the first display portion 62A and the second display portion 62B are integrated with their surroundings is when the color difference between the first display portion 62A and the surrounding membrane 66Y is less than 3.0, and when the color difference between the second display portion 62B and the surrounding membrane 66Y is less than 3.0. On the other hand, the state in which the first display portion 62A and the second display portion 62B are distinguishable from their surroundings (not integrated) is when the color difference between the first display portion 62A and the surrounding membrane 66Y is 3.0 or more, and when the color difference between the second display portion 62B and the surrounding membrane 66Y is 3.0 or more. Before the color development, the wearer has difficulty recognizing the first display portion 62A and the second display portion 62B.

[0051] As shown in FIG. 9(B), during the test, the complex and the colored antibody migrate from the conjugate pad 66X, and the skin surface of the membrane 66Y is colored by the colored antibody and the complex colored by the colored antibody. The wearer can visually recognize the colored antibody and the colored complex during the test, allowing them to understand that the test is progressing. As the test progresses, the complex and the colored antibody move through the second indicator movement section 66A2 and then to the terminal movement section 66B. FIG. 9(C) shows the state after coloring, in which the first indicator section 62A is colored by the complex, and the second indicator section 62B is colored by the labeled antibody (including the colored antibody). The complex and the labeled antibody not captured by the first indicator section 62A and the second indicator section 62B migrate to the absorption section 67 and are adsorbed by the absorption section 67. In this way, the presence of the colored antibody allows the wearer to understand the test progress. The indicator section captures and colors at least one of the complex and the labeled antibody. By coloring the complex, the color developed by capturing the complex becomes more noticeable. Also, the color developed by capturing the colored antibody becomes more noticeable. Therefore, the display area after color development becomes more noticeable, and the wearer can more easily understand the test results.

[0052] However, some wearers may visually recognize the colored antibodies when viewing the test member 60 before use, which may give them the false impression that a color reaction has occurred, even though the color reaction has not yet occurred. The absorbent article 1 according to the present embodiment is configured to prevent this misunderstanding by the wearer. More specifically, the absorbent article 1 has a colored region R20 that covers the skin side T1 of the colored antibodies provided in the transfer section 66. The colored region R20 only needs to cover the skin side T1 of the colored antibodies before use of the test member 60, i.e., before the colored antibodies have transferred, and does not need to cover the skin side T1 of the colored antibodies that have transferred during the test process. Because the skin side T1 of the colored antibodies provided in the transfer section 66 is covered by the colored region R20 before use of the absorbent article 1, when the wearer views the absorbent article 1 before use from the skin side T1, the colored antibodies are located on the back side of the colored region R20, making it difficult to directly view the colored antibodies. The colored antibody is difficult for the wearer to see before use, and the wearer is prevented from mistakenly thinking that the test member 60 has already reacted before using the absorbent article 1 .

[0053] The colored region R20 is configured to be visible from the skin side T1 of the absorbent article 1 before use of the absorbent article 1. Therefore, by visually checking the colored region R20, the wearer can recognize that the absorbent article 1 has the test member 60, and can recognize the presence of the test member 60 and that the test results should be understood. The absorbent article 1 is used not only for testing but also for everyday use, and both absorbent articles 1 with the test member 60 and absorbent articles without the test member 60 may be used as appropriate. The user can recognize that the absorbent article 1 has the test member 60 by visually checking the colored region R20. Furthermore, even if the user puts on an absorbent article with the test member 60 for testing, they may forget that testing is underway while wearing it. Even in such cases, when visually checking the absorbent article 1, such as when replacing the absorbent article 1, the user can notice the presence of the test member 60 and properly understand the test results.

[0054] The colored region R20 may be provided on a component of the absorbent article 1 that is located on the skin side T1 of the colored antibody. The colored region R20 may be provided on the test member 60 itself, or on a component (e.g., a top sheet, a skin-side cover sheet, etc.) located closer to the skin side T1 than the test member 60. The colored region R20 may be provided on a single layer of sheet, or on multiple layers, with the colored regions overlapping in the thickness direction. The colored region R20 may be a portion of the sheet itself colored with a pigment or the like, or a portion of the sheet partially colored by printing or the like. The colored region R20 may cover at least a portion of the colored antibody before coloring, but preferably covers the entire colored antibody (the entire region R1 colored by the colored antibody). In a configuration having both an antibody not bound to a molecule contributing to coloring and the colored antibody, the colored region R20 may cover at least the colored antibody, but may not necessarily cover the antibody not bound to a molecule contributing to coloring. In this embodiment, the colored region R20 is provided on the non-skin side of the test skin side sheet 68 that constitutes the test member. The test skin side sheet 68 is made of a transparent resin film. The portion of the transparent resin film that is colored with ink or the like constitutes the colored region R20, and the uncolored portion constitutes the high-transmittance region R25. Before coloring, the colored region R20 covers the region R1 that is colored by the colored antibody in the conjugate pad 66X.

[0055] The test member 60 may be visible from the skin side T1 of the absorbent article 1 before use of the absorbent article 1. Note that, before use of the absorbent article 1, the indicator 62 is in a state before coloring. Therefore, the visibility of the test member 60 before use of the absorbent article can be replaced with the visibility of the test member 60 before coloring of the indicator 62. Note that the state in which the test member 60 is visible before use of the absorbent article 1 only needs to be a state in which at least a portion of the test member 60 before coloring is visible. Furthermore, it is sufficient that the user can recognize the presence of the test member 60, and this includes not only a configuration in which the test member 60 is directly visible, but also a state in which the skin side surface of the absorbent article 1 is raised by the test member 60 and the presence of the test member can be recognized by the raised portion. Because the test member 60 is visible from the skin side T1 of the absorbent article 1 before use of the absorbent article 1, the position of the test member 60 on the absorbent article 1 can be recognized when wearing the absorbent article 1. The wearer puts on the absorbent article 1 while being aware of the presence of the inspection member 60, so that the inspection member 60 can be placed in an appropriate position.

[0056] The display unit 62 after coloring may be visible from the skin side T1 of the absorbent article 1. Because the display unit 62 after coloring is visible from the skin side T1 of the absorbent article 1, the wearer can easily understand the test results by visually viewing the absorbent article 1 from the skin side T1 of the absorbent article 1 without peeling the absorbent article 1 off the worn article or taking the absorbent article 1 off the worn article. Note that the display unit 62 only needs to be visible from the skin side T1 of the absorbent article 1 at least after coloring, and may be invisible from the skin side T1 of the absorbent article 1 before coloring, or may be visible from the skin side T1 of the absorbent article 1 before coloring.

[0057] The state in which the absorbent article 1 is visible from the skin side may be such that the visible light transmittance is 60% or more when a member positioned closer to the skin than the object for which visibility is to be evaluated (for example, the test member when evaluating the visibility of the test member 60) is overlapped. Alternatively, the state in which the absorbent article 1 is visible from the skin side means that the object can be seen by a subject with good visual acuity (1.0 or better) in both eyes when looking at the object from the skin side T1 of the absorbent article 1 at a distance of approximately 30 to 50 cm in a room (approximately 500 to 750 lx (lux)) that is brightly lit with daylight white light (approximate color temperature: 4600 to 5400 K (Kelvin)).

[0058] The test member 60 may be disposed on the non-skin side T2 of the top sheet 11 and on the skin side T1 of the back sheet 21. The test member 60 is visible through the top sheet 11 from the skin side T1 of the absorbent article 1. The top sheet 11 may have a visible light transmittance of 60% or more. This allows the wearer to more clearly see the color of the indicator unit after color change through the top sheet 11, making it easier to determine whether the indicator unit 62 has changed color. The color difference between the top sheet 11 and the indicator unit 62 after color change may be 0.6 or more, and preferably 3.0 or more. This configuration makes it less likely that the color of the indicator unit 62 after color change will be similar to the color of the top sheet 11, making it easier to view the indicator unit 62 after color change. The user can easily determine whether the indicator unit has changed color without removing the test member 60 from the absorbent article, making it easier to check the user's health condition simply and accurately.

[0059] Before the display unit 62 changes color, the test member 60 may be visible from the skin side T1 of the absorbent article 1 but not from the non-skin side T2 of the absorbent article 1. Because the test member 60 is visible from the skin side T1 of the absorbent article 1 before the display unit 62 changes color, the position of the test member 60 on the absorbent article 1 can be determined when wearing the absorbent article 1, and the test member 60 can be positioned appropriately. Before the display unit 62 changes color, the test member 60 is not visible from the non-skin side T2 of the absorbent article 1. Therefore, the user can intuitively determine whether the test member 60 is on the skin side or not based on whether the test member 60 is visible, thereby improving operability when wearing the absorbent article 1. Furthermore, the colored antibody may not be visible from the non-skin side T2 of the absorbent article 1 before use. Therefore, even when viewed from the non-skin side T2 of the absorbent article 1, misidentification of the absorbent article 1 before use can be reduced.

[0060] The state in which the absorbent article 1 is not visible from the non-skin side T2 may be such that the visible light transmittance is 20% or less when a member located on the non-skin side T2 is overlapped with an object for which visibility is to be evaluated (for example, the test member when evaluating the visibility of the test member 60). Alternatively, the state in which the absorbent article 1 is not visible from the non-skin side means that an object cannot be seen when viewed from the non-skin side T2 of the absorbent article 1 by a subject with good visual acuity (1.0 or better) in both eyes at a distance of approximately 30 to 50 cm in a room brightly lit with daylight white light (approximate color temperature: 4600 to 5400 K (Kelvin)) (approximate color temperature: 500 to 750 lx (lux)).

[0061] The inspection member 60 may be positioned closer to the skin side T1 than the absorbent core 31. The inspection member 60 is positioned closer to the skin side T1 than the absorbent core 31, and the skin side T1 is not covered by the absorbent core 31. This makes it easy to ensure visibility of the inspection member 60 when viewed from the skin side T1 of the absorbent article 1. When putting on the absorbent article 1, the wearer can put on the absorbent article 1 while being aware of the presence of the inspection member 60, and the inspection member 60 can be positioned in an appropriate position. Furthermore, after the inspection by the inspection member 60, the wearer can easily understand the inspection results.

[0062] The top sheet 11 and the back sheet 21 are composed of sheets having fibers, and the average inter-fiber distance of the back sheet 21 may be smaller than the inter-fiber distance of the top sheet 11. With this configuration, before and after coloring of the indicator 62, the test member 60 is easily visible from the skin side T1 of the absorbent article 1 and is difficult to see from the non-skin side T2 of the absorbent article 1. This makes it easier to ensure visibility of the test member 60 from the skin side T1 of the absorbent article 1, and improves operability when putting on the absorbent article 1 by increasing the distinguishability between the skin side and non-skin side of the absorbent article 1. The average inter-fiber distance can be evaluated, for example, by measuring the average inter-fiber distance of the surface to be measured (the skin side of the top sheet 11) using a microscope, and measuring the average inter-fiber distance of the non-skin side of the back sheet 21 using a microscope. The microscope method used a 3D image stitching function on a microscope (KEYENCE VHX-2000, lens VH-Z20W, aperture fully open) to obtain an enlarged image in focus from the skin-side surface of the sample to a depth of 100 μm, and then extract the outer area of ​​the fibers in focus based on the enlarged image. The surface formed there was defined as a fiber space. The diameter of the largest inscribed circle in the fiber space was defined as the fiber space distance, and the average value of 100 fiber spaces was defined as the average inter-fiber distance. The fiber density of the backsheet 21 may be higher than the fiber density of the topsheet 11. Because the fibers of the backsheet 21 are dense and the fibers of the topsheet 11 are sparse, visibility through the backsheet 21 is low and visibility through the topsheet 11 is high, making it easy to view the test member 60 from the skin side T1 of the absorbent article 1 and difficult to view the test member 60 from the non-skin side T2 of the absorbent article 1.

[0063] As shown in FIG. 8 , the test member 60 is divided into five equal regions in the second direction (the width direction W in this embodiment). The five regions include a center region RC located at the center of the test member 60 in the second direction and side regions RS located at both ends of the test member 60 in the second direction. The center region RC straddles the center of the test member 60 in the second direction. The side regions RS extend from the outer edges of the test member 60 in the second direction to the inside in the second direction (in the case where the second direction is the width direction as in this embodiment, from the outer edges 60E of the test member in the width direction to the inside in the width direction). The display unit 62 may be located at least in the center region RC. The display unit 62 may extend outward in the second direction beyond the center region RC, may be located between the center region RC and the side regions RS, or may be continuously located from the center region RC to the side regions RS.

[0064] The average thickness of the center region RC of the test member 60 may be greater than the average thickness of the side regions RS of the test member 60. The center region RC has a greater average thickness than the side regions RS, ensuring a larger volume of space for the movement of excrement components. Therefore, excrement components are more likely to move along the first direction in the center region RC, and a color reaction is more likely to occur in the indicator 62 in the center region RC. By causing a color reaction in the center region RC, which is located at the center of the test member 60 in the second direction, the wearer can easily visually recognize the color reaction, improving the visibility of the test results. Additionally, the edges of the test member in the second direction are surrounded by regions that absorb excrement, such as the absorbent core and top sheet 11, which may reduce visibility due to excrement absorbed in the surrounding regions. On the other hand, the center region RC is located away from the excrement absorbed in the surrounding regions, making visibility less likely to be reduced by the excrement. Therefore, the color reaction in the indicator 62 of the center region RC allows the wearer to easily understand the test results. The average thickness may be calculated by measuring 10 points in each region using a cross-sectional photograph of a cross section along the second direction (see, for example, FIG. 7 ). The thickness of the center region RC and the thickness of the side region RS are the distance in the thickness direction between the skin-side surface of the test member 60 and the non-skin-side surface of the test member 60 in each region. The thickness of the indicator is the distance in the thickness direction between the skin-side surface of the indicator and the non-skin-side surface of the indicator. The thickness of the top sheet 11 is the distance in the thickness direction between the skin-side surface of the top sheet 11 and the surface of the top sheet 11. The side regions RS are located at both ends of the test member in the second direction. The average thickness of at least one side region may be thinner than the average thickness of the center region RC, but preferably the average thickness of both side regions may be thinner than the average thickness of the center region RC.

[0065] As shown in FIG. 6 and elsewhere, the test member 60 is composed of multiple components with respective functions, such as a moving section 66 and a display section 62. The top sheet 11 may cover at least a portion of the test member 60, but may also cover the entire test member 60. In a configuration in which the average thickness of the side regions RS is thinner than the average thickness of the center region RC and the top sheet 11 covers the entire test member 60, the edges of the test member 60 are less likely to get caught, even if external forces are applied to the test member 60 due to the wearer's movements during wear. This prevents curling of the edges of the test member 60 and misalignment between the components constituting the test member, thereby maintaining test accuracy. Furthermore, preventing curling and creasing of the edges of the test member also prevents localized changes in the thickness and density of each component. Localized changes in thickness and density may stagnate the movement of excrement components in the affected areas or hinder color reactions. However, it is possible to suppress local variations in the thickness and density of each component, and to suppress a decrease in inspection accuracy.

[0066] The density of the center region RC is lower than that of the side regions RS. The density can be calculated by cutting each region with the same planar dimensions within the range including the cross section where the average thickness was measured, and using the weight of each region and the average thickness. The center region RC has sparser components within and between the components than the side regions RS, while the side regions RS have denser components within and between the components than the center region RC. Excrement components moving in the test member 60 move more easily in the relatively sparse center region RC and less easily in the relatively dense side regions RS. Therefore, excrement components move more easily in the first direction in the center region RC, and a color reaction is more likely to occur in the display area in the center region RC. By showing a color reaction at the center of the test member in the second direction, the wearer can easily visually recognize the color reaction, improving the visibility of the test results.

[0067] In a cross section along the second direction, the average thickness of the indicator 62 in the center region RC may be thicker than the average thickness of the indicator 62 in the side region RS. The indicator 62 in the center region RC is more likely to show a color reaction. By making it easier for a color reaction to occur in the center of the test member 60 in the second direction, the wearer can more easily visually recognize the color reaction, improving the visibility of the test results. In a configuration in which the indicator is formed by an indicator disposed on a membrane, as in the present embodiment, the average thickness of the membrane in the center region RC may be thicker than the average thickness of the membrane in the side region RS.

[0068] The average thickness of the top sheet 11 in the region covering the side region RS may be thicker than the average thickness of the top sheet 11 in the region covering the center region RC. Because the average thickness of the top sheet 11 covering the center region RC is thin, bodily fluid can be quickly guided from the top sheet 11 side to the test member 60 side without being retained in the top sheet 11. This makes it easier for a color reaction to occur in the indicator 62 in the center region RC. By causing a color reaction to occur at the center of the test member 60 in the second direction, the wearer can easily visually recognize the color reaction, improving the visibility of the test results. The side regions RS are located at both ends of the test member in the second direction. The average thickness of the top sheet 11 covering at least one side region may be thicker than the average thickness of the top sheet 11 covering the center region RC, but preferably, the average thickness of both top sheets 11 covering both side regions may be thicker than the average thickness of the top sheet 11 covering the center region RC.

[0069] In a configuration in which the average thickness of the top sheet 11 in the area covering the side region RS is thicker than the average thickness of the top sheet 11 in the area covering the center region RC, and the entire area of ​​the inspection member 60 is covered by the top sheet 11, the thickness of the top sheet 11 covering the side region RS is relatively thick, so the top sheet 11 absorbs external forces on the edges of the inspection member, preventing curling at the edges of the inspection member and misalignment between the components that make up the inspection member.

[0070] The density of the top sheet 11 in the region covering the center region RC may be higher than the density of the top sheet 11 in the region covering the side regions RS. Because the density of the top sheet 11 covering the center region RC is relatively high and the density of the top sheet 11 covering the side regions RS is relatively low, the top sheet 11 can guide excrement from the side regions RS to the center region RC and guide excrement components to the center in the second direction, thereby promoting a color reaction at the center in the second direction of the test member.

[0071] To further promote the color reaction at the center of the test member 60 in the second direction, the indicator 62 at the center in the second direction may be configured to stand out. For example, the area ratio of the indicator 62 in the center region RC may be configured to be higher than the area ratio of the indicator 62 in the side regions RS. Alternatively, the basis weight of the indicator constituting the indicator 62 may be different, and the basis weight of the indicator in the center region RC may be higher than the basis weight of the indicator in the side regions RS.

[0072] The first direction may be the front-to-rear direction L, and the second direction may be the width direction W. When worn, the absorbent article is pinched between the legs and is susceptible to forces directed from the outside to the inside in the width direction. Therefore, the outer edges of the test member in the width direction are more susceptible to external forces than the center of the test member in the width direction. However, when the average thickness of the side regions is thinner than that of the center region, the relatively thin side regions are less susceptible to external forces, suppressing deformation of the outer portions of the test member and allowing a color reaction based on excrement components to occur without inhibiting the movement of excrement components. Furthermore, when the average thickness of the top sheet in the region covering the side regions is thicker than that of the top sheet in the region covering the center region, the relatively thick top sheet absorbs external forces related to the side regions, suppressing deformation of the outer portions of the test member and allowing a color reaction based on excrement components to occur without inhibiting the movement of excrement components. Furthermore, in a configuration in which the density of the side region located on the outer part of the test member is high, deformation of the outer part of the test member is suppressed, and a color reaction based on the excrement components can be exhibited without hindering the movement of the excrement components.

[0073] The inspection member 60 may be positioned biased to one side in the front-to-rear direction with respect to the center of the front-to-rear direction L of the absorbent article 1, and the contact portion 64 may be positioned at the end of the inspection member 60 on the other side in the front-to-rear direction. For example, the inspection member 60 may be biased forward with respect to the center of the front-to-rear direction L of the absorbent article 1, and the contact portion 64 may be positioned at the rear end of the inspection member 60. Alternatively, the inspection member 60 may be biased rearward with respect to the center of the front-to-rear direction L of the absorbent article 1, and the contact portion 64 may be positioned at the front end of the inspection member 60. The contact portion 64 is positioned at the end of the inspection member on the other side in the front-to-rear direction, and is located toward the center of the absorbent article in the front-to-rear direction, making it easy to position it near the excretion opening. Therefore, the contact portion can smoothly draw in excrement. Preferably, the inspection member 60 may be biased forward with respect to the center of the front-to-rear direction L of the absorbent article 1. With this configuration, the test member 60 is easily visible to the wearer, allowing the wearer to easily recognize the presence of the test member 60 and easily visually confirm the test results. The other end of the contact portion 64 may be covered by a non-skin-side sheet rather than by a skin-side sheet (described later). The other end of the contact portion is covered by a liquid-impermeable non-skin-side sheet, which prevents contact with excrement from the non-skin side, while being uncovered by the skin-side sheet makes it easier for excrement from the skin side to come into contact with the other end.

[0074] The inspection member 60 may be arranged in a central portion in the width direction W of the absorbent article 1. At least a part of the inspection member 60 may be arranged in a central portion in the width direction W of the absorbent article 1. This configuration makes it easier to arrange the contact portion 64 facing the excretion opening. By arranging the inspection member 60 facing the excretion opening, it is easier to guide excrement to the inspection member 60, and after inspection by the inspection member, the wearer can easily understand the inspection results. The central portion in the width direction W of the absorbent article 1 includes the center of the width direction W of the absorbent article 1, and may be in a range of 10 mm outward from the center in the width direction. Preferably, the inspection member 60 may be arranged across the center of the width direction W of the absorbent article 1. The contact portion 64 of the inspection member 60 may be arranged in the crotch region S3.

[0075] In a plan view of the absorbent article, the inspection member 60 may be disposed at an angle with respect to the front-rear direction L of the absorbent article 1. The inspection member 60 disposed at an angle with respect to the front-rear direction L may be disposed such that the outer edge of the inspection member 60 in the width direction W is not parallel to the front-rear direction L but is inclined, or such that the inspection center line connecting the center of the width direction W at the front end of the inspection member 60 and the center of the width direction W at the rear end of the inspection member 60 is not parallel to the front-rear direction L but is inclined. By slanting the inspection member 60 with respect to the front-rear direction L of the absorbent article 1, the inspection member 60 becomes more noticeable relative to the outer edges of other components of the absorbent article 1 (e.g., the top sheet, the absorbent core), making it easier for the user to recognize the presence of the inspection member 60. Preferably, the length of the inspection member 60 in the front-rear direction L may be longer than the length of the inspection member 60 in the width direction W. This makes it easier for the wearer to recognize the inclined state of the inspection member 60. The angle formed between the inspection center line of the inspection member 60 and the front-rear direction L may be 20 degrees or less, and preferably may be 3 degrees or more and 10 degrees or less.

[0076] The compressing section 35 may have a first compressing section 351 and a second compressing section 352 arranged on either side of the inspection member 60 in the width direction W. The first compressing section 351 and the second compressing section 352 may be arranged at an interval in the width direction W, with the inspection member 60 disposed between the first compressing section 351 and the second compressing section 352. As shown in FIG. 3 , the distance G11 between the first compressing section 351 and the inspection member 60 in the width direction W may be different from the distance G12 between the second compressing section 352 and the inspection member 60 in the width direction W. Note that when comparing the distances G11 and G12, they are compared on the same imaginary line extending parallel to the width direction W. Furthermore, in an embodiment in which a plurality of first compressing sections 351 and a plurality of second compressing sections 352 are provided, the comparison is made between compressing sections having shapes that are symmetrical with respect to a center line that passes through the center of the absorbent article 1 in the width direction and extends in the front-to-rear direction L. The first compressing portion 351 and the second compressing portion 352 may extend in the front-to-rear direction L. By having the first compressing portion 351 and the second compressing portion 352 extend in the front-to-rear direction L, it becomes easier to make the inspection member stand out relatively to the first compressing portion and the second compressing portion. Note that the configuration in which the compressing portion 35 extends in the front-to-rear direction L includes not only a linear configuration extending in the front-to-rear direction, but also a configuration in which a collection of multiple compressing portions arranged at intervals is arranged extending in the front-to-rear direction.

[0077] The outer portion of the inspection member 60 may be formed with convex portions that protrude outward in the width direction W and concave portions that are recessed inward in the width direction W relative to the convex portions. The convex portions and concave portions may be alternately formed in line in the front-to-rear direction L. This configuration makes the outer portion of the inspection member 60 more noticeable, making it easier for the user to recognize the presence of the inspection member 60. The widthwise length of the convex portions and the widthwise length of the concave portions may be 20 μm or more and 60 μm or less, and the front-to-rear length of the convex portions and the front-to-rear length of the concave portions may be 50 μm or more and 400 μm or less.

[0078] In a cross section taken along the front-to-rear direction L, the skin-side surface of the test member 60 may be inclined toward the non-skin side T2 from the center of the test member 60 in the front-to-rear direction L toward the outer end of the test member 60. Because the skin-side surface is inclined toward the non-skin side T2 toward the outside of the test member 60 in the front-to-rear direction L, when bodily fluid reaches the skin-side surface of the test member 60, the bodily fluid can be guided toward the non-skin side T2 while being guided toward the outside of the test member 60 in the front-to-rear direction L. This makes it difficult for bodily fluid to remain on the test member 60, thereby preventing bodily fluid from reaching the test member 60 through unintended paths. Furthermore, because the body fluid is unlikely to remain on the test member 60, a decrease in visibility due to remaining body fluid can be prevented.

[0079] As shown in Figures 7 and 8, in a cross section taken along the width direction W, the skin-side surface of the test member 60 may be inclined toward the non-skin side T2 from the center of the width direction W of the test member 60 toward the outer edge of the test member 60. Because the test member 60 is inclined toward the non-skin side T2 toward the outer edge of the width direction W, when bodily fluid reaches the skin-side surface of the test member 60, the bodily fluid can be guided toward the non-skin side T2 while being guided toward the outer edge of the width direction W of the test member 60. This makes it difficult for bodily fluid to remain on the test member 60, thereby preventing bodily fluid from reaching the test member 60 through unintended paths. Furthermore, this also makes it difficult for bodily fluid to remain on the test member 60, thereby preventing a decrease in visibility due to remaining bodily fluid. To determine whether the skin-side surface of the test member is inclined toward the non-skin side, a photograph of a cross section taken along the front-to-rear direction or the width direction of the test member may be used to visually confirm whether the test member has an inclined portion. Alternatively, the test member may be divided into five equal parts in the front-to-back or width direction, and the position of the skin surface of the central portion may be compared with the position of the skin surface of the end portion to determine whether the skin surface of the test member is inclined toward the non-skin side. The configuration in which the skin surface of the test member is inclined toward the non-skin side may be such that the end portions of the test member are pressed more tightly than the center and have a higher density, or such that the number of materials or basis weight of the material at the end portions of the test member is smaller than that at the center.

[0080] 8, the skin side sheet may be inclined toward the non-skin side from the center in the width direction W of the skin side sheet toward the outer edge in the width direction W of the skin side sheet. Excrement discharged onto the skin side sheet is guided along the skin side sheet from the center in the width direction toward the side in the width direction to the non-skin side. This prevents the excrement from being guided directly to the moving section, and allows the excrement to be guided from the side in the width direction of the inspection member toward the non-skin side.

[0081] The color of the colored antibody provided in the transfer section 66 may be similar to the color of the colored region R20. According to this configuration, the colored antibody can be concealed by the similarly colored colored region R20, making the colored antibody less noticeable. When comparing the color of the colored antibody provided in the transfer section with the color of the colored region, the color of the colored antibody provided in the transfer section itself, i.e., the color of the colored antibody not covered by the colored region, is compared with the color of the colored region. Similar colors include the same color. In this specification, "different" colors refer to a difference in hue of 5 or more (preferably 8 or more, more preferably 10 or more), a difference in brightness of 1 or more (preferably 2 or more, more preferably 3 or more), or a difference in saturation of 1 or more (preferably 2 or more, more preferably 3 or more) in the Munsell color system (100 hues). Furthermore, in this specification, "similar" or "similar colors" refers to a difference in hue of less than 5, lightness of less than 1, or saturation of less than 1 in the Munsell color system (100 hues), and includes cases where the colors are identical. Alternatively, "different" colors may refer to a color difference ΔE of 1 or more, preferably ΔE of 2 or more, more preferably ΔE of 3 or more, and even more preferably ΔE of 5 or more. In this case, "similar" or "similar colors" refer to a color difference ΔE of less than 1. Note that a whitish color is a color with an L* of 70 or more, preferably a color with an L* of 80 or more, and more preferably a color with an L* of 90 or more. The above color difference is measured as follows. (1) Prepare an X-Rite eXact Standard (measuring diameter: 1.5 mm) manufactured by X-Rite. (2) Measure the CIE L*a*b* coordinates of the part of the sample to be measured at 10 or more points in different positions and calculate the average value ([L1*, a1*, b1*]). (3) Measure the L*a*b* coordinates of the part of the sample to be compared at 10 or more points in different positions and calculate the average value ([L2*, a2*, b2*]). (4) Calculate the color difference ΔE using the following formula (Equation 1).

[0082] The color difference between the color of the colored antibody provided in the transfer section 66 and the color of the colored region R20 may be 3.0 or more. While the colored region R20 has the effect of concealing the colored antibody, the color of the colored antibody and the color of the colored region R20 are different, making it easier for the wearer to understand the process of the colored antibody moving during the test and the coloration caused by the complex after the test is completed. This reduces misidentification before use and improves the visibility of the test results.

[0083] The color difference between the area of ​​the colored region R20 that overlaps with the colored antibody in the thickness direction T and the area of ​​the colored region R20 that does not overlap with the colored antibody may be 3.0 or more. The colored region R20 has the effect of concealing the colored antibody while allowing the wearer to identify the area where the colored antibody is located. The wearer can identify the area where the colored antibody is located and handle the absorbent article carefully by identifying parts that may affect the test, such as wearing the absorbent article without touching the area where the colored antibody is located. This prevents a decrease in test accuracy.

[0084] The skin side T1 of the first display portion 62A and the second display portion 62B does not have to be covered by the colored region R20. That is, the colored region R20 may be disposed in a region that does not overlap with the first display portion 62A and the second display portion 62B in the thickness direction T. This configuration ensures visibility of the first display portion 62A and the second display portion 62B from the skin side T1 of the absorbent article 1, allowing the wearer to understand the test results.

[0085] The brightness of the region where the colored region R20 is arranged on the skin side T1 of the absorbent article 1 may be lower than the brightness of the region where the first indication unit 62A is arranged after coloring. Because the brightness of the region where the colored region R20 is arranged is lower than the brightness of the region where the first indication unit 62A is arranged, the first indication unit 62A is less noticeable than the colored region R20 when viewed from the skin side T1 of the absorbent article 1 after coloring. This prevents the colored labeled antibody from being visible from the skin side T1 of the absorbent article before use, while making the first indication unit 62A more noticeable after coloring, allowing the wearer to easily understand the test results. Furthermore, the brightness of the region where the colored region R20 is arranged on the skin side T1 of the absorbent article 1 may be lower than the brightness of the region where the second indication unit 62B is arranged after coloring. Because the brightness of the area where the colored area R20 is arranged is lower than the brightness of the area where the second display unit 62B is arranged, when viewed from the skin side of the absorbent article after coloring, the second display unit 62B is more noticeable than the colored area R20. Thus, while preventing the colored labeled antibody from being visible from the skin side of the absorbent article before use, the second display unit 62B can be made to stand out after coloring, allowing the wearer to easily understand the test results.

[0086] In a modified example, the brightness of the region where the colored region R20 is arranged on the skin side T1 of the absorbent article may be higher than the brightness of the region where the first display unit 62A is arranged after coloring. According to this aspect, the brightness of the region where the colored region R20 is arranged is higher than the brightness of the region where the first display unit 62A is arranged, and when viewed from the skin side of the absorbent article after coloring, the colored region R20 is more noticeable than the first display unit 62A. The visibility of the colored region R20, which does not cover the display unit, makes it easier for the wearer to distinguish between the colored region R20 and the first display unit 62A, and the wearer can easily understand the test results. Furthermore, the brightness of the region where the colored region R20 is arranged on the skin side of the absorbent article may be higher than the brightness of the region where the second display unit 62B is arranged after coloring. According to this aspect, the brightness of the area where the colored area R20 is arranged is higher than the brightness of the area where the second display portion 62B is arranged, and when viewed from the skin side of the absorbent article after coloring, the colored area R20 is more noticeable than the second display portion 62B. Because the colored area R20 that does not cover the display portion is more noticeable, the wearer can easily distinguish between the colored area R20 and the second display portion 62B, and the wearer can easily understand the test results.

[0087] The lightness may be the lightness in the Munsell color system, and can be measured by visual colorimetry, which involves visually judging the color (hue, lightness, and saturation) of the object to be measured by comparing it with a color sample. Specifically, for example, using an expanded version of the Munsell System Color Ruler published by Nippon Shikiken Jigyo Co., Ltd., the lightness can be judged visually by visually comparing the color (hue, lightness, and saturation) of the object to be measured with the Munsell symbols (color sample) on a numerical scale with equal intervals.

[0088] The colored region R20 may be provided on a liquid-impermeable sheet. According to this configuration, the skin side T1 of the colored antibody is covered by the liquid-impermeable sheet. Therefore, excrement can be prevented from reaching the colored antibody side directly from the skin side T1 of the colored antibody. The excrement reaches the area where the colored antibody is provided after passing through a predetermined path (the contact portion in this embodiment). This prevents a decrease in test accuracy due to excrement components other than those required for the test reaching the area where the colored antibody is provided, thereby improving test accuracy. In this embodiment, the sheet on which the colored region R20 is provided is a liquid-impermeable test skin-side sheet 68. The test skin-side sheet 68 does not cover the skin side T1 of a portion of the contact portion 64, but covers the transfer portion 66 and the display portion 62. Therefore, excrement is guided to the transfer portion 66 and the display portion 62 via the contact portion 64, preventing the excrement from reaching the transfer portion and the display portion directly. The contact part acts as a filter and can guide excrement components required for testing from the excrement to the transfer part and the display part.

[0089] The liquid-impermeable sheet provided with the colored region R20 may have a high-transmittance region R25 having a visible light transmittance higher than that of the colored region R20. The display unit 62 may be covered by the high-transmittance region R25. The high-transmittance region may be a region of the liquid-impermeable sheet where no colored region is provided. Because the display unit 62 is covered by the high-transmittance region R25, visibility of the display unit 62 can be ensured. Furthermore, by covering the skin side T1 of the display unit 62 with the liquid-impermeable sheet, it is possible to prevent excrement from reaching the display unit directly from the skin side. The high-transmittance region R25 may cover at least a portion of the display unit 62, but preferably covers the entire display unit 62.

[0090] The colored region R20 may have a first colored region R21 that covers the colored antibody of the moving portion, and a second colored region R22 that covers the skin side T1 of the absorbent portion 67. By covering the absorbent portion 67 with the second colored region R22, the colored absorbent portion 67 becomes difficult to see when the wearer views the absorbent article 1 from the skin side T1. Making the colored absorbent portion 67 difficult to see makes the display portion 62 stand out relatively, and improves the visibility of the test results.

[0091] The first colored region R21 and the second colored region R22 may be arranged at an interval in the front-to-rear direction L. The display unit 62 may be arranged between the colored regions R20 in the front-to-rear direction L. By covering the moving portion 66 and the absorbing portion 67 with the colored region R20 and arranging the display unit 62 between the colored regions R20, the moving portion 66 and the absorbing portion 67 are concealed, making the display unit 62 stand out relatively, and making it easier for the wearer to focus on the test results.

[0092] Furthermore, by providing the first colored region R21 and the second colored region R22 on either side of the display unit 62 in the front-to-back direction L, the range in which the test results are displayed can be indicated to the wearer. The first and second display units 62A and 62B change color by capturing the complex and the labeled antibody. Before coloring, they are difficult to see from the skin side T1 of the absorbent article 1. This can make it difficult for the wearer to identify the area in which the test results are displayed. However, by sandwiching the display unit 62 between the first and second colored regions R21 and R22, the area in which the test results are displayed is divided by the first and second colored regions R21 and R22, making it easier for the wearer to identify the area in which the test results are displayed. The areas of the first and second colored regions R21 and R22 may be larger than the combined area of ​​the first and second display units 62A and 62B. By increasing the area of ​​the first colored region R21 and the area of ​​the second colored region R22, the area in which the test result is displayed becomes clearer. In the vertically elongated test member 60 as in the present embodiment, the length in the front-rear direction L of the first colored region R21 and the length in the front-rear direction L of the second colored region R22 may be longer than the total length of the front-rear direction L of the first display portion 62A and the length in the front-rear direction L of the second display portion 62B. By increasing the length in the front-rear direction L of the first colored region R21 and the length in the front-rear direction L of the second colored region R22, the area in which the test result is displayed becomes clearer.

[0093] The absorbent article 1 may include a first hydrophobic portion 71 having hydrophobic properties that covers the skin side T1 of the display portion 62 of the inspection member. By having the first hydrophobic portion 71 cover the skin side T1 of the display portion 62, it is possible to prevent excrement from reaching the display portion 62 directly from the skin side T1 of the display portion 62. This makes it possible to prevent the visibility of the display portion 62 from being reduced by excrement that has directly reached the display portion 62. Note that it is sufficient for the first hydrophobic portion 71 to cover at least a portion of the skin side T1 of the display portion 62, but it may preferably cover the skin side T1 of the entire display portion 62 (first display portion 62A and second display portion 62B).

[0094] In this embodiment, the first hydrophobic section 71 is composed of the skin-side cover sheet 18 and the test skin-side sheet 68. The first hydrophobic section 71 may be composed of only one of the skin-side cover sheet 18 and the test skin-side sheet 68. Both the skin-side cover sheet 18 and the test skin-side sheet 68 are liquid-impermeable sheets and constitute the "skin-side sheet" of the present invention. That is, the skin-side sheet covers the skin side T1 of the display unit 62. Covering the skin side T1 of the display unit 62 with the liquid-impermeable skin-side sheet prevents excrement from reaching the display unit 62 directly from the skin side T1 of the display unit 62. The skin-side cover sheet 18 is a separate sheet from the test member 60 and is located closer to the skin side T1 than the test skin-side sheet 68. The test skin-side sheet 68 is a sheet that constitutes the test member 60. The test skin side sheet 68 constitutes the "first skin side sheet" of the present invention, and the skin side cover sheet 18 constitutes the "second skin side sheet" of the present invention.

[0095] The hydrophobic portion (including the first hydrophobic portion 71, the second hydrophobic portion 72, and the third hydrophobic portion 73) may be a portion with low liquid permeability, in which liquid permeation is reduced compared to the surrounding area, or a portion with liquid impermeability, in which liquid does not pass through. The hydrophobic portion may be a portion to which a hydrophobic coating agent is applied, or a portion to which a liquid-impermeable sheet is disposed. Examples of the hydrophobic coating agent include an adhesive (HMA type adhesive) and a water repellent agent (silicone). FIG. 3 shows the width direction ranges of the first hydrophobic portion 71, the second hydrophobic portion 72, and the third hydrophobic portion 73.

[0096] The first hydrophobic portion 71 only needs to cover at least the skin side T1 of the display portion 62, and may cover the skin side T1 of the region of the test member 60 other than the display portion 62. The first hydrophobic portion 71 may cover the skin side T1 of the moving portion 66. Covering the skin side T1 of the moving portion with the first hydrophobic portion 71 makes it difficult for excrement to directly reach the moving portion, thereby improving test accuracy. Furthermore, the first hydrophobic portion 71 does not need to cover at least a portion of the skin side T1 of the contact portion 64. Because the first hydrophobic portion 71 does not cover at least a portion of the skin side T1 of the contact portion 64, excrement is guided into the contact portion 64 via at least a portion of the contact portion 64, and then guided to the moving portion 66 via the contact portion 64. Covering the skin side T1 of the moving portion 66 with the first hydrophobic portion 71 prevents excrement from directly reaching the moving portion 66. Therefore, the excrement components required for the test can be guided to the transfer portion 66 via the contact portion 64, improving the test accuracy. Improved test accuracy allows accurate test results to be displayed quickly, allowing the user to easily understand the test results. While the first hydrophobic portion 71 may cover at least a portion of the skin side T1 of the transfer portion 66, it is preferable that the first hydrophobic portion 71 cover the skin side T1 of the entire transfer portion 66.

[0097] The first hydrophobic portion 71 may be disposed so as to cover the skin side T1 of a portion other than the contact portion 64. The first hydrophobic portion 71 can be configured so that excrement comes into direct contact only with a predetermined region (a portion) of the contact portion 64, and the portion other than the contact portion 64 is likely to exhibit a filtering function that moves only the necessary components to the transfer portion 66 side.

[0098] The skin-side sheet (in this embodiment, the skin-side cover sheet 18) constituting the first hydrophobic portion 71 may be positioned closer to the skin side T1 than the test member 60 and may be positioned across the contact portion 64, the moving portion 66, and the display portion 62. The skin-side sheet spans the contact portion 64, the moving portion 66, and the display portion 62, and is continuous from the contact portion 64 to the display portion 62. The continuous first hydrophobic portion 71 prevents excrement from penetrating the test member through gaps between the first hydrophobic portions 71, thereby preventing excrement from reaching the test member via unintended routes. The skin-side sheet constituting the first hydrophobic portion 71 may cover only a portion of the skin side of the contact portion 64 (it does not have to cover the entire contact portion), preferably covering less than 50% of the entire area of ​​the contact portion, more preferably less than 20% of the entire area of ​​the contact portion, and even more preferably less than 10% of the entire area of ​​the contact portion.

[0099] As shown in FIG. 6 , a hollow portion HP may be formed between the skin-side sheet and the display unit 62. That is, the non-skin-side surface of the skin-side sheet and the skin-side surface of the display unit 62 may be spaced apart in the thickness direction T. According to this configuration, when a force is applied from the skin side T1 of the absorbent article 1 toward the test member 60 due to pressure during wear, the hollow portion HP can absorb the pressure from the skin side T1. This prevents the display unit 62 from being crushed by pressure during wear, allowing the display unit 62 to display the test results. In this embodiment, in the region anterior to the display unit 62, the absorbent unit 67 and the second colored region R22 are disposed between the membrane 66Y and the test skin-side sheet 68. In the region posterior to the display unit 62, the conjugate pad 66X and the sample pad 64Z are disposed between the membrane 66Y and the test skin-side sheet 68. Therefore, a hollow portion HP is formed between the display portion 62 and the skin-side sheet, preventing the display portion 62 from being pressed by the skin-side sheet. Preferably, the thickness of the sample pad 64Z and the conjugate pad 66X may be 0.5 mm or greater. The hollow portion HP is a space formed between the components constituting the test member. The hollow portion HP may be provided in an area other than between the skin-side sheet and the display portion 62 (between the test skin-side sheet 68 and the display portion). As shown in FIG. 8 , the hollow portion HP may be provided between the sample pad 64Z and the non-test skin-side sheet 69, between the conjugate pad 66X and the colored region R20, or between the membrane 66Y and the test skin-side sheet 68.

[0100] The visible light transmittance of the skin-side sheet constituting the first hydrophobic portion 71 may be higher than the visible light transmittance of the absorbent core 31. Because the visible light transmittance of the skin-side sheet constituting the first hydrophobic portion 71 is relatively high, it is possible to prevent the presence of the skin-side sheet from reducing the visibility of the test member 60. By covering the display portion 62 with the skin-side sheet, it is possible to prevent the visibility of the display portion 62 from being reduced by excrement that reaches the display portion 62 directly from the skin side T1, while also preventing the reduction in visibility of the test member 60 due to the high visible light transmittance.

[0101] The absorbent article 1 may include a second hydrophobic portion 72 having hydrophobic properties and covering the non-skin side T2 of the display portion 62 of the test member 60. The absorbent core 31 may be positioned closer to the non-skin side T2 than the second hydrophobic portion 72. Because the second hydrophobic portion 72 covers the non-skin side T2 of the display portion 62 and is positioned between the test member 60 and the absorbent core 31, it is possible to prevent excrement absorbed in the absorbent core 31 from directly transferring to the display portion 62. It is possible to prevent the visibility of the display portion 62 from being reduced by excrement absorbed in the absorbent core 31. The test member 60 is positioned closer to the skin side T1 than the absorbent core 31, and the skin side T1 is not covered by the absorbent core 31. This makes it easy to ensure the visibility of the display portion 62 when viewed from the skin side T1 of the absorbent article 1. The user can easily understand the test results. The second hydrophobic portion 72 may cover at least a portion of the non-skin side T2 of the display portion 62, but preferably may cover the entire non-skin side T2 of the display portion 62 (the first display portion 62A and the second display portion 62B).

[0102] The second hydrophobic section 72 in this embodiment is composed of a non-skin-side cover sheet 19 and a test non-skin-side sheet 69. The second hydrophobic section 72 may be composed of only one of the non-skin-side cover sheet 19 and the test non-skin-side sheet 69. Both the non-skin-side cover sheet 19 and the test non-skin-side sheet 69 are liquid-impermeable sheets and constitute the "non-skin-side sheet" of the present invention. That is, the non-skin-side sheet covers the non-skin-side T2 of the display section 62. Covering the non-skin-side T2 of the display section 62 with a liquid-impermeable non-skin-side sheet prevents excrement absorbed in the absorbent core 31 from migrating to the display section 62, thereby preventing the visibility of the display section 62 from being reduced by excrement migrating from the absorbent core 31. The non-skin-side cover sheet 19 is a separate sheet from the test member 60 and is located closer to the non-skin-side T2 than the test non-skin-side sheet 69. The test non-skin-side sheet 69 is a sheet that constitutes the test member 60. The test non-skin side sheet 69 constitutes the "first non-skin side sheet" of the present invention, and the non-skin side cover sheet 19 constitutes the "second non-skin side sheet" of the present invention.

[0103] The second hydrophobic portion 72 only needs to cover at least the non-skin side T2 of the display portion 62, and may cover the non-skin side T2 of the region of the test member 60 other than the display portion 62. The second hydrophobic portion 72 may cover the non-skin side T2 of the contact portion 64 and the non-skin side T2 of the moving portion 66. Because the second hydrophobic portion 72 covers the non-skin side T2 of the contact portion 64 and the non-skin side T2 of the moving portion 66, it is possible to prevent excrement absorbed in the absorbent core 31 from migrating to the contact portion 64 and the moving portion 66. This allows excrement components necessary for the test to be guided to the moving portion 66 via the contact portion 64, improving test accuracy. Improved test accuracy allows accurate test results to be displayed quickly, allowing the user to easily understand the test results. The second hydrophobic portion 72 may cover at least a portion of the non-skin side T2 of the moving portion 66 and at least a portion of the non-skin side T2 of the contact portion 64, but preferably may cover the entire non-skin side T2 of the moving portion 66 and the entire non-skin side T2 of the contact portion 64.

[0104] The non-skin-side cover sheet 19, which serves as a non-skin-side sheet, covers the non-skin side T2 of the test member 60 and may be positioned across the outer edge of the test member 60 in the width direction W. The non-skin-side cover sheet 19, which is separate from the test member 60, can prevent excrement from penetrating into the test member from the non-skin side of the test member. The skin-side cover sheet 18, which serves as a skin-side sheet, covers the skin side T1 of the test member 60 and may be positioned across the outer edge of the test member 60 in the width direction W. The skin-side cover sheet 18, which is separate from the test member 60, can prevent excrement from penetrating into the test member 60 from the skin side T1 of the test member 60.

[0105] The bending rigidity of the non-skin-side cover sheet 19 may be lower than the bending rigidity of the side regions of the test member 60. Because the bending rigidity of the non-skin-side cover sheet 19 covering the non-skin side T2 of the test member 60 is relatively low, the non-skin-side T2 region is more easily deformed than the test member 60, making the test member 60 less likely to feel stiff. Furthermore, because the bending rigidity of the side regions is relatively high, curling of the test member 60 is suppressed. Furthermore, the bending rigidity of the non-skin-side cover sheet 19 may be lower than the bending rigidity of the non-skin-side test sheet 69. The non-skin-side cover sheet 19 is positioned closer to the non-skin side T2 than the non-skin-side test sheet 69. Because the bending rigidity of the non-skin-side cover sheet 19 covering the non-skin side T2 of the test member 60 is relatively low, the non-skin-side T2 region is more easily deformed than the test member 60, making the test member 60 less likely to feel stiff.

[0106] The bending rigidity of the skin-side cover sheet 18 may be lower than the bending rigidity of the side regions of the test member 60. Because the bending rigidity of the skin-side cover sheet 18 covering the skin side T1 of the test member 60 is relatively low, the region of the skin side T1 is more easily deformed than the test member 60, making the test member 60 less likely to feel stiff. Because the bending rigidity of the side regions is relatively high, curling of the test member 60 is suppressed. The bending rigidity of the skin-side cover sheet 18 may be lower than the bending rigidity of the test skin-side sheet 68. The skin-side cover sheet 18 is positioned closer to the skin side T1 than the test skin-side sheet 68. Because the bending rigidity of the skin-side cover sheet 18 covering the skin side T1 of the test member 60 is relatively low, the region of the skin side T1 is more easily deformed than the test member 60, making the test member 60 less likely to feel stiff.

[0107] Here, the bending rigidity can be measured by the KES method. Specifically, this can be performed using a KES-FB2-AUTO-A bending tester manufactured by Kato Tech Co., Ltd., and samples of a size that allows measurement of both the cover sheet and the test member are prepared. It is preferable to measure the bending rigidity of the test member by cutting out a sample so that it includes the portion containing the antibody, and measuring the rigidity of the portion containing the antibody. Next, each sample is fixed between the chucks of the tester so that the lateral bending rigidity of each sample can be measured. The sample is bent to a maximum curvature of +2.5 cm-1 toward the front, then bent to a maximum curvature of -2.5 cm-1 toward the back, and then returned to its original position. The bending rigidity value is calculated from the average of the slope of the bending moment relative to the curvature when the slope becomes approximately constant after the first bending toward the front, and the slope when the slope becomes approximately constant after the first bending toward the back. This measurement is repeated five times for each sample, and the average value is used as the bending rigidity.

[0108] The skin-side sheet and the non-skin-side sheet may abut at least on the outside in the width direction of the test member 60. In this embodiment, the skin-side cover sheet 18 as the skin-side sheet and the non-skin-side cover sheet 19 as the non-skin-side sheet abut at the outside in the width direction W of the test member 60. The abutting skin-side sheet and the non-skin-side sheet prevent excrement from entering from the skin side T1, the non-skin side T2, and the sides of the test member 60, and prevent excrement from reaching the test member through unintended paths. The skin-side sheet and the non-skin-side sheet may abut at least on the outside in the front-to-back direction of the test member. In this embodiment, the skin-side cover sheet 18 and the non-skin-side cover sheet 19 abut at the outside in the width direction W of the test member 60. The skin-side cover sheet 18 and the non-skin-side cover sheet 19 abutting against each other inhibit the intrusion of excrement from the skin side T1, the non-skin side T2, and the sides of the test member 60, thereby inhibiting excrement from reaching the test member 60 through unintended paths. Preferably, the skin-side cover sheet 18 and the non-skin-side cover sheet 19 may be joined outside the test member 60 in the width direction W. Examples of such joining include joining with an adhesive or joining by welding such as thermal welding. This configuration further inhibits the intrusion of excrement from the skin side, the non-skin side, and the sides of the test member 60, thereby further improving test accuracy.

[0109] The outer edges of the skin-side sheet and the non-skin-side sheet may be misaligned in the width direction W. That is, the outer edge of the skin-side coversheet 18 may be misaligned in the width direction W with at least one of the outer edges of the non-skin-side coversheet 19 and the outer edge of the test non-skin-side sheet 69. The outer edge of the test skin-side sheet 68 may be misaligned in the width direction with at least one of the outer edges of the non-skin-side coversheet 19 and the outer edge of the test non-skin-side sheet 69. The absorbent article 1 is sandwiched between the legs and receives a force from the outside toward the inside in the width direction W. At this time, the outer edges of the non-skin-side sheet and the outer edges of the skin-side sheet are misaligned in the width direction, and multiple deformation base points are provided at intervals in the width direction W, gradually weakening the force received from the outside in the width direction W, allowing the shape of the test member 60 to be maintained while also softening contact with the legs and reducing discomfort when worn. Furthermore, the outer edge of the skin-side cover sheet 18 and the outer edge of the test skin-side sheet 68 may be misaligned in the width direction W, and the outer edge of the non-skin-side cover sheet 19 and the outer edge of the test non-skin-side sheet 69 may be misaligned in the width direction W. With this configuration, the outer edges of the sheets are arranged in more stages, providing more deformation base points and gradually weakening the force acting from the outside in the width direction toward the test member.

[0110] The outer edge of the test member 60 in the front-to-rear direction may be covered by at least one of the first non-skin-side sheet (test non-skin-side sheet 69), the second non-skin-side sheet (non-skin-side cover sheet 19), the first skin-side sheet (test skin-side sheet 68), and the second skin-side sheet (skin-side cover sheet 18). Covering the outer edge of the test member with any of the sheets can reduce discomfort when worn due to the rigidity of the test member. In the front-to-rear direction L, the outer edge of the first non-skin-side sheet, the outer edge of the second non-skin-side sheet, the outer edge of the first skin-side sheet, and the outer edge of the second skin-side sheet may be offset. Note that it is sufficient if at least one of the outer edges of the four sheets is offset, and preferably, all of the outer edges of each sheet are offset. Since the outer edge of the first non-skin-side sheet, the outer edge of the second non-skin-side sheet, the outer edge of the first skin-side sheet, and the outer edge of the second skin-side sheet are offset in the front-to-back direction, multiple deformation base points can be provided at intervals in the front-to-back direction, and the absorbent article having the inspection member can be positioned along the front-to-back curves of the body.

[0111] The absorbent article 1 may include third hydrophobic portions 73 that are disposed on both sides of the test member 60 in the width direction W and have hydrophobic properties. The third hydrophobic portions 73 are disposed outward in the width direction from the outer edges of the test member 60 in the width direction W, and suppress the intrusion of excrement from the sides of the test member 60. The length in the width direction W of each third hydrophobic portion 73 may be longer than the length in the width direction W of the test member 60. The length in the width direction W of the third hydrophobic portion 73 is longer than the length in the width direction W of the test member 60, and can suppress the intrusion of excrement from the sides of the test member over a wide range extending from the test member 60 outward in the width direction W. This makes it difficult for excrement to be disposed adjacent to the sides of the test member, and suppresses a decrease in the visibility of the test member due to excrement accumulating on the sides of the test member. The third hydrophobic portion 73 in the embodiment is composed of a portion that extends outward in the width direction W from the inspection member on the non-skin side cover sheet 19, and a portion that extends outward in the width direction W from the inspection member on the skin side cover sheet 18.

[0112] The skin side T1 of the test member 60 may be covered with a sheet that is less breathable than the top sheet 11. The sheet that is less breathable than the top sheet 11 may have lower breathability than the top sheet 11, or may be non-breathable. Covering the skin side of the test member 60 with a sheet that is less breathable than the top sheet 11 prevents the test member 60 from drying out from the skin side T1 of the test member 60. The test member 60 can maintain an appropriate humidity level, and when excrement and excrement components are guided, the excrement components can be smoothly transported, allowing for appropriate testing. In this embodiment, a skin-side cover sheet 18 is disposed on the non-skin side T2 of the top sheet 11 and on the skin side T1 of the test member 60. The skin-side cover sheet 18 is made of a transparent resin film, and the breathability of the skin-side cover sheet 18 is lower than the breathability of the top sheet 11. The skin-side cover sheet 18 constitutes a sheet that is less breathable than the top sheet 11. Furthermore, the widthwise length and front-to-rear length of the skin-side cover sheet 18 are shorter than those of the members (e.g., the top sheet 11, the auxiliary sheet 15, and the absorbent core 31) arranged around the skin-side cover sheet 18, and the breathability of the members arranged around the skin-side cover sheet 18 is higher than that of the skin-side cover sheet 18. The high breathability of the members arranged around the skin can ensure the fluidity and breathability of bodily fluids within the absorbent article.

[0113] As shown in Figure 6, the skin-side cover sheet 18, like the test skin-side sheet, does not cover the skin side T1 of a portion of the sample pad 64Z (the area of ​​the sample pad not covered by the conjugate pad), but covers the skin side T1 of the area of ​​the sample pad 64Z covered by the conjugate pad 66X, the conjugate pad 66X, the membrane 66Y, and the entire absorbent portion 67. The skin-side cover sheet 18 also prevents excrement from directly reaching the moving portion 66 and the display portion 62. The width of the skin-side cover sheet 18 is longer than the width of the test member 60, and the outer edges on both sides of the skin-side cover sheet 18 may be positioned outward in the width direction W from the outer edges of the test member 60. The skin-side cover sheet 18 prevents excrement from penetrating from the skin side and sides of the test member, thereby preventing excrement from reaching the test member 60 via unintended paths. In the width direction of the absorbent article, the outer edges on both sides of the skin-side cover sheet 18 may be positioned outward from the outer edges of the test skin-side sheet 68. The skin-side cover sheet 18 prevents excrement from penetrating from the skin side T1 and sides of the test member 60, and prevents excrement from reaching the test member 60 through unintended routes.

[0114] The skin-side coversheet 18 is disposed between the top sheet 11 and the inspection member 60, and may be configured to be visible through the top sheet 11 from the skin side T1 of the absorbent article 1. By recognizing the presence of the skin-side coversheet 18, the wearer is assured that the inspection member 60 is protected, allowing them to use the absorbent article 1 with peace of mind. If the skin-side coversheet 18 is made of a resin film, the skin-side coversheet 18 is easily noticeable when the absorbent article 1 is viewed from the skin side T1 of the absorbent article 1 due to the diffuse reflection of light from the resin film. Therefore, the wearer can recognize the presence and position of the inspection member 60 by focusing on the skin-side coversheet 18.

[0115] The test member 60 is disposed on the skin side T1 of the absorbent core 31, and the absorbent article 1 may have a liquid-impermeable non-skin-side cover sheet 19 disposed between the test member 60 and the absorbent core 31. Covering the non-skin side T2 of the test member 60 with the liquid-impermeable non-skin-side cover sheet 19 can prevent excrement absorbed in the absorbent core 31 from migrating to the display section 62. This can prevent the visibility of the display section 62 from being reduced by excrement absorbed in the absorbent core 31. Furthermore, necessary excrement components can be guided to the display section 62 via the contact section 64, improving the accuracy of the test.

[0116] The test member 60 is positioned closer to the skin side T1 than the absorbent core 31, and the non-skin side T2 of the test member 60 may be covered with a sheet that is less breathable than the absorbent core 31. The sheet that is less breathable than the absorbent core 31 may have lower breathability than the absorbent core 31, or may be non-breathable. Covering the non-skin side T2 of the test member 60 with a sheet that is less breathable than the absorbent core 31 prevents the test member 60 from drying out from the non-skin side T2 of the test member 60. The test member 60 can maintain an appropriate humidity level, and when excrement and excrement components are introduced, the excrement components can be smoothly transported, allowing for appropriate testing. In this embodiment, the non-skin side cover sheet 19 is made of a resin film, and the breathability of the non-skin side cover sheet 19 is lower than that of the absorbent core 31. The non-skin side cover sheet 19 constitutes a sheet that is less breathable than the absorbent core 31. Furthermore, the widthwise length and front-to-rearwise length of the non-skin-side cover sheet 19 are shorter than those of the members (e.g., the top sheet 11, the auxiliary sheet 15, and the absorbent core 31) arranged around the non-skin-side cover sheet 19, and the breathability of the members arranged around the non-skin-side cover sheet 19 is higher than that of the non-skin-side cover sheet 19. The high breathability of the members arranged around the non-skin-side cover sheet 19 ensures the fluidity and breathability of bodily fluids within the absorbent article.

[0117] The breathability of the back sheet 21 may be higher than the breathability of at least one of the skin-side cover sheet 18 and the non-skin-side cover sheet 19. At least one of the skin-side cover sheet 18 and the non-skin-side cover sheet 19 can prevent the test member from drying out, while the back sheet can prevent stuffiness after the absorbent core has absorbed body fluids.

[0118] As shown in FIG. 6 , the skin-side cover sheet 18 may be shifted rearward relative to the test skin-side sheet 68. The skin-side cover sheet 18 may extend forward relative to the leading edge of the test member 60. The non-skin-side cover sheet 19 may be shifted rearward relative to the test non-skin-side sheet 69. The non-skin-side cover sheet 19 may extend rearward relative to the trailing edge of the test member 60. The non-skin-side cover sheet 19 covers the entire non-skin side T2 of the sample pad 64Z, conjugate pad 66X, and membrane 66Y. The width of the non-skin-side cover sheet 19 is longer than the width of the test member 60, and both outer edges of the non-skin-side cover sheet 19 may be positioned outward in the width direction W relative to the outer edges of the test member 60. The non-skin-side cover sheet 19 prevents excrement from entering the test member 60 from the non-skin side T2 and sides, preventing excrement from reaching the test member 60 via unintended paths. In the width direction of the absorbent article, the outer edges on both sides of the non-skin-side cover sheet 19 may be positioned outboard of the outer edges of the non-skin-side test sheet 69. The non-skin-side cover sheet 19 prevents excrement from penetrating from the non-skin side T2 and sides of the test member 60, and prevents excrement from reaching the test member 60 through unintended routes.

[0119] The test member 60 of the present embodiment tests the wearer's health condition from vaginal discharge. As described above, vaginal discharge is a suitable target for testing health among bodily waste, but the amount excreted is small and it can be difficult to detect. Furthermore, vaginal discharge has a high viscosity among bodily waste, making it difficult for it to reach the test member 60, making it difficult to obtain appropriate test results. For this reason, the top sheet 11 of the present embodiment is configured to enable appropriate testing of health using vaginal discharge. Next, the configuration of the top sheet 11 will be described in detail.

[0120] The top sheet 11 is positioned closer to the skin side T1 than the test member 60 and contacts the wearer's skin surface. Vaginal discharge excreted by the wearer is applied to the skin side of the top sheet 11, permeates through the top sheet 11, and is guided to the test member 60 side. The top sheet 11 allows 6% or more of an artificial body fluid having a viscosity of 15 to 30 Pa·s at 23°C (hereinafter referred to as the predetermined viscosity) that is in contact with the skin side of the top sheet 11 to permeate to the non-skin side of the top sheet. As a result of extensive research by the applicant, it has been found that the viscosity of typical vaginal discharge is 15 to 30 Pa·s at 23°C, and that an artificial body fluid of this predetermined viscosity exhibits a permeation behavior similar to that of vaginal discharge. The top sheet 11 allows a high proportion of 6% or more of the artificial body fluid of this predetermined viscosity that is in contact with the skin side T1 surface to permeate to the non-skin side of the top sheet 11. Therefore, even vaginal discharge, which has a higher viscosity than urine and menstrual blood, can permeate the top sheet 11 and be guided to the test member 60, and even a small amount of vaginal discharge can be permeated through the top sheet 11 at a high rate and be guided to the test member 60, thereby obtaining appropriate test results based on the vaginal discharge. The artificial body fluid permeation test, which measures the artificial body fluid that permeates the top sheet, will be described in detail below.

[0121] When a sufficient amount of artificial body fluid is to be measured, viscosity is measured as follows: (1) Prepare the following equipment: HAAKE RheoStress 1 (sensor: cone φ60 mm, 1° angle C60 / 1) manufactured by Thermo Fisher Scientific Co., Ltd. (2) Place 38 ml of the antibacterial fluid to be measured in a container attached to the equipment, and immerse the measuring element in the artificial body fluid. (3) Measure viscosity under the following conditions: temperature 23°C, humidity 60%, shear rate: 10.0 (l / s)

[0122] The top sheet 11 may be configured to allow 6% or more of the artificial body fluid that comes into contact with the skin-side surface of the top sheet 11 to permeate to the non-skin-side surface of the top sheet 11 when the skin-side surface of the top sheet 11 is pressed against the wearer with a pressure of 1.60 to 1.70 kPa. When worn, the absorbent article 1 is subjected to various forces. As a result of extensive research by the applicant, it has been found that the skin-side surface of the top sheet 11 comes into a pressed state in which it is pressed against the wearer with a pressure of at least 1.60 to 1.70 kPa in various situations, such as when the wearer changes their position or when the worn article with the absorbent article 1 is pulled up. In this case, 6% or more of the artificial body fluid that comes into contact with the skin-side surface T1 of the top sheet 11 is permeated to the non-skin-side surface of the top sheet 11, so that vaginal discharge that has permeated the top sheet 11 can be guided to the testing member 60, and appropriate test results can be obtained based on the vaginal discharge.

[0123] The absorbent article 1 may be an absorbent article that is fastened to the inner surface of a wearing article S when used. The pressed state may be a state in which the outer surface of the wearing article S is pressed toward the wearer so that the skin-side surface of the top sheet 11 of the absorbent article 1 abuts against the wearer's skin. Fig. 10 schematically shows a cross section along the width direction of the wearing article S with the absorbent article 1 attached to it when worn by a wearer. Fig. 10 shows a state in which the absorbent article 1 is pressed toward the wearer and a state in which the absorbent article 1 is not pressed toward the wearer. For ease of explanation, Fig. 10 omits all components of the absorbent article 1 other than the testing member 60, the skin-side cover sheet 18, and the non-skin-side cover sheet 19. In Fig. 10 , V schematically indicates the vaginal opening, S indicates the wearing article, and F indicates the wearer's finger.

[0124] Figure 10(A) shows an example of a state in which the wearing article S with the absorbent article 1 attached is not pressed against the wearer, i.e., in a normal wearing state. Unlike sanitary napkins, panty liners absorb a small amount of body waste and are not used for a specific period of time like sanitary napkins, but are used daily. Therefore, unlike sanitary napkins, which are used together with sanitary shorts, panty liners are often used attached to everyday underwear. As a result, panty liners are not pressed against the wearer like sanitary napkins are pressed by sanitary shorts, and a gap is likely to form between the wearer and the absorbent article 1, as shown in Figure 10(A). Pubic hair around the vaginal opening V also tends to create a gap between the wearer and the absorbent article 1.

[0125] To perform an inspection using the inspection member 60, the wearer can intentionally press the outer surface of the worn article S toward the wearer so that the skin-side surface of the top sheet 11 of the absorbent article 1 comes into contact with the wearer's skin. This pressure by the wearer is typically achieved with a finger, so as not to apply excessive force to the delicate genital area, and the wearer presses the gap between the skin-side surface of the top sheet 11 of the absorbent article 1 and the wearer's skin. Fig. 10(B) shows a state in which a finger is placed against the non-skin-side surface of the worn article, while Fig. 10(C) shows a state in which the finger is pressed against the outer surface of the worn article S toward the wearer. As a result of extensive research by the applicant, when the wearer presses the outer surface of the worn article S toward the wearer with their finger, the top sheet 11 is pressed toward the wearer with a pressure of at least 1.60 to 1.70 kPa. In this pressed state, vaginal discharge that has passed through the top sheet 11 is guided toward the inspection member 60, thereby obtaining appropriate inspection results based on the vaginal discharge.

[0126] The top sheet 11 and the test member 60 may abut against each other. It is sufficient that at least a portion of the skin-side surface of the test member 60 abuts against the non-skin-side surface of the top sheet 11. In the absorbent article 1 of this embodiment, a skin-side cover sheet 18 is disposed between the top sheet 11 and the test member 60. The skin-side cover sheet 18 does not cover a portion of the sample pad 64Z serving as the contact portion 64. Therefore, the top sheet 11 and the test member 60 abut against each other in the area where the skin-side cover sheet 18 is not disposed. With this configuration, vaginal discharge can be directly guided to the test member 60 via the top sheet 11, allowing the excrement to be quickly and reliably guided to the test member 60. Note that, in order to ensure permeability to body fluids, it is preferable that no adhesive be applied to the area where the top sheet 11 and the test member 60 abut.

[0127] The length in the width direction W of the inspection member 60 may be shorter than the width of a woman's finger. When a finger is placed on the wearing article S along the front-to-rear direction L of the absorbent article and pressed against it, the width of the finger is arranged along the width direction W of the inspection member 60. Since the length in the width direction W of the inspection member 60 is shorter than the width of a woman's finger, the entire inspection member 60 can be pressed with the finger. Here, in this specification, "finger width" does not mean the thickness of the finger, but specifically refers to the width of the finger in the direction in which the nail spreads. In consideration of the action of placing a finger on the outer surface of a wearing article and pressing against it, the "finger width" may be at least one of the widths of a typical woman's middle finger, index finger, and ring finger, and is set to, for example, 10 mm.

[0128] The length in the width direction W of the non-skin-side coversheet 19 covering the non-skin-side side of the test member 60 may be shorter than the finger width. According to this configuration, when a finger is placed against the worn article 1 and pressed along the front-to-rear direction L of the absorbent article 1, the finger can press the entire width direction W of the test member 60 with the finger via the non-skin-side coversheet 19. Furthermore, the length in the width direction W of the skin-side coversheet 18 covering the skin side T1 of the test member 60 may be shorter than the finger width. As shown in FIG. 10(C) , when the outer surface of the worn article S is pressed toward the wearer, the skin-side coversheet 18 is disposed flat, and the test member 60 is also likely to be disposed along this flat surface facing the excretion opening. Furthermore, if the length in the width direction W of the skin-side coversheet 18 is longer than the test member 60, the test member 60 can be pressed so as to face the excretion opening across the entire width direction W of the test member 60.

[0129] The inspection member 60 may be arranged across the center of the width direction W of the absorbent article 1. When a wearer places their finger against the inspection member 60 to press it, they are aware that the finger is placed against the excretory opening V, and can easily place their finger so that it touches the center of the width direction W of the absorbent article 1. Therefore, the inspection member arranged across the center of the width direction W of the absorbent article 1 can be pressed toward the wearer by pressing the inspection member 60. The inspection member 60 may have a vertically elongated shape in which the length in the front-to-rear direction L of the inspection member 60 is longer than the length in the width direction W. When a wearer places their finger against the worn article to press it along the front-to-rear direction L of the absorbent article 1, it is easy to place the finger along the inspection member 60, and a certain range of the inspection member 60 extending in the front-to-rear direction L can be pressed with the finger, allowing the inspection member 60 to be positioned closer to the body.

[0130] The top sheet 11 is composed of a sheet having fibers, and the average inter-fiber distance of the top sheet 11 may be longer than the average diameter of a woman's pubic hair. The average diameter of pubic hair may be the average diameter of an adult woman, specifically 90 μm. According to this configuration, because the average inter-fiber distance of the top sheet 11 is longer than the average diameter of a woman's pubic hair, pubic hair is more likely to penetrate into the top sheet 11 when the top sheet 11 comes into contact with the wearer's skin. Vaginal discharge adhering to pubic hair is more likely to transfer to the top sheet 11. Preferably, the average inter-fiber distance on the skin-facing surface of the top sheet 11 may be longer than the average diameter of a woman's pubic hair. When the skin-facing surface of the absorbent article is pressed against the wearer, pubic hair is more likely to penetrate into the top sheet.

[0131] The contact portion 64 of the test member 60 and the top sheet 11 are composed of sheets having fibers, and the average inter-fiber distance of the top sheet 11 may be longer than the average inter-fiber distance of the contact portion 64. Excrement discharged into the absorbent article 1 is guided to the contact portion 64 via the top sheet 11. Excrement in the top sheet 11 is more likely to transfer to the contact portion 64, which has a narrower average inter-fiber distance, making it easier for even a small amount of vaginal discharge to reach the test member 60. The fiber density of the top sheet 11 may be higher than the fiber density of the contact portion 64. Excrement is more likely to transfer from the top sheet 11, which has a relatively high fiber density, to the contact portion 64, which has a relatively low fiber density, making it easier for even a small amount of vaginal discharge to reach the test member 60.

[0132] The contact portion 64 may contact the top sheet 11 in the non-compressed region. It is sufficient that at least a portion of the contact portion 64 contacts the top sheet 11 in the non-compressed region, and a portion of the contact portion may contact the top sheet 11 in the compressed region. The top sheet 11 in the non-compressed region does not have the irregularities caused by the compressed portion 35 as compared to the top sheet 11 in the compressed region, and is therefore more likely to come into surface contact with the contact portion 64. Excrement within the top sheet 11 will more easily migrate to the contact portion 64, making it easier for the test member 60 to reach even a small amount of vaginal discharge.

[0133] The average thickness of the top sheet 11 in the region covering the contact portion 64 may be thicker than the average thickness of the top sheet 11 in the region covering the transfer portion 66. The top sheet 11 covering the contact portion 64 has a thicker average thickness, ensuring a large volume of space for retaining excrement. Therefore, the top sheet 11 in the region covering the contact portion 64 can absorb a larger amount of excrement, making it easier for the excrement to transfer from the top sheet 11 to the contact portion 64.

[0134] The non-skin-side cover sheet 19 is a liquid-impermeable sheet and may cover the entire width direction W of the test member 60. The outer edges on both sides of the non-skin-side cover sheet 19 may extend further outward in the width direction W than the outer edges of the test member 60. According to this configuration, by covering the non-skin side T2 of the test member 60 with a liquid-impermeable sheet over the entire width direction W of the test member 60, excrement that reaches the test member 60 is prevented from penetrating through the test member 60 to the non-skin side T2, making it easier for the excrement to move within the test member 60.

[0135] The contact angle of the artificial body fluid with the top sheet 11 may be smaller than the contact angle of the artificial body fluid with the wearer's skin. Here, "contact angle" evaluates wettability; the smaller the contact angle, the easier it is to wet and absorb the artificial body fluid. The contact angle is evaluated using the above-described artificial body fluid. As a result of extensive research by the applicant, it was found that a PET plate exhibits hydrophilicity very similar to that of skin. Therefore, the contact angle with skin is the contact angle with the PET plate. The contact angle is measured as follows: (1) In a thermostatic chamber at 25°C, an automatic contact angle meter CA-V type (manufactured by Kyowa Interface Science Co., Ltd.), a polyethylene terephthalate plate (hereinafter referred to as the "PET plate"), and a top sheet are prepared. The PET plate is PET-6010 (manufactured by Takiron C.I. Co., Ltd., size: 41.5 x 80.0 x 1.0 mm). (2) Approximately 2 μL of the wiping ability improver is dropped onto each of the PET plate and the top sheet using a syringe, and 5 seconds after the dropping, the contact angle of the wiping ability improver is measured using an automatic contact angle meter, CA-V model, by the θ / 2 method. (3) The measurement is performed 10 times at different locations on each of the PET plate and the top sheet, and the average value of these measurements is used as the contact angle.

[0136] The test element 60 of this embodiment is a test element using immunochromatography to detect luteinizing hormone from vaginal discharge. The immunochromatographic test element forms a complex with excrement components through an antigen-antibody reaction, which then develops a color with an indicator at the destination of the complex, indicating the test result. Therefore, a larger amount of excrement is required than in tests using test strips. However, according to the present invention, even a small amount of vaginal discharge can be guided to the test element, allowing for immunochromatographic testing.

[0137] The absorbent article 1 may be folded around the crease before use, and at least the indicator 62 of the test member 60 may be arranged in an area that does not overlap with the crease. No creases due to the crease are formed in the indicator 62, ensuring visibility of the indicator 62. Preferably, the test member 60 may be arranged in an area that does not overlap with the crease. No creases due to the crease are formed in the test member 60, making it easier to position the test member 60 along the body and guiding even small amounts of vaginal discharge to the test member. A fastening portion 25 may be arranged in an area that overlaps with the test member 60 in the thickness direction. The area where the test member 60 is arranged can be fastened to the worn article via the fastening portion 25, and the test member 60 can be pressed toward the wearer via the worn article, making it easier to guide even small amounts of vaginal discharge to the test member.

[0138] The absorbent article is preferably configured so that adhesives do not inhibit the transfer of excrement. As shown in FIG. 3 , the components constituting the absorbent article are joined to each other by adhesively bonded regions. More specifically, a first adhesive region 551 is provided between the top sheet 11 and the skin-side coversheet 18. No adhesive region is provided between the skin-side coversheet 18 and the test member 60. A second adhesive region 552 is provided between the test member 60 and the non-skin-side coversheet 19. No adhesive region is provided between the non-skin-side coversheet 19 and the auxiliary sheet 15. A third adhesive region 553 is provided between the auxiliary sheet 15 and the absorbent core 31. A fourth adhesive region 554 is provided between the absorbent core 31 and the backsheet 21. As shown in FIG. 6 , non-adhesive regions where no adhesive is provided are provided on the surfaces where the moving portion 66, the display portion 62, the contact portion 64, and the absorbent portion 67 contact each other. More specifically, a non-adhesive region is provided on the surface where the moving portion 66 and the display portion 62 come into contact, a non-adhesive region is provided on the surface where the moving portion 66 and the contact portion 64 come into contact, and a non-adhesive region is provided on the surface where the moving portion 66 and the absorption portion 67 come into contact. According to this aspect, since no adhesive is provided on the surfaces where the constituent members come into contact with each other, the presence of adhesive is prevented from interfering with the movement of excrement components, and the test can be performed accurately and precisely.

[0139] Next, a preferred method for manufacturing a test element configured as described above will be described. Note that only a portion of the steps of the manufacturing method will be described below; steps other than these steps can be adopted from known manufacturing methods. The manufacturing method includes at least a laminating step in which components constituting the moving section, the display section, and the absorbent section are arranged between a non-skin-side test continuous sheet (continuous sheet) comprising a series of sheets constituting the non-skin-side test sheet 69 and a skin-side test continuous sheet (continuous sheet) comprising a series of sheets constituting the skin-side test sheet 68; and a cutting step in which the laminate formed by the laminating step is cut along the edge of the test element in the second direction. The cutting step presses the laminate in the thickness direction T to cut the laminate. According to this manufacturing method, during the process of cutting the laminate, the edge of the test element in the second direction is pressed, and the side region RS, which is the end of the test element in the second direction, is pressed more than the center region RC, resulting in a thinner thickness of the side region RS than the center region RC. Furthermore, the side region RS is pressed more than the center region RC, resulting in a higher density in the side region RS than the center region RC. Preferably, the laminating step does not apply adhesive to the surfaces where the contact portion 64 and the moving portion 66 meet, the surfaces where the components constituting the moving portion (the conjugate pad 66X and the membrane 66Y) meet, the surfaces where the moving portion 66 meets the display portion 62, and the surfaces where the moving portion 66 meets the absorbent portion 67. The cutting step may involve fusing the laminate and joining the edges of the test member in the second direction by fusing. The surfaces where the contact portion 64 and the moving portion 66 meet, the surfaces where the components constituting the moving portion (the conjugate pad 66X and the membrane 66Y) meet, the surfaces where the moving portion 66 meets the display portion 62, and the surfaces where the moving portion 66 meets the absorbent portion 67 are areas where excrement components move. This configuration prevents adhesives from interfering with the permeation of excrement. Furthermore, by fusing the edges of the test member in the second direction, the components can be joined without adhesive, thereby preventing adhesives from interfering with the permeation of excrement. In the lamination process, the process of constructing the moving section, display section, and absorbent section between the test non-skin side continuous sheet and the test skin side continuous sheet may involve arranging the moving section, display section, and absorbent section in a state where they are cut to the dimensions of the test member, or arranging a continuous body in which the members constituting the moving section, display section, and absorbent section are connected.When the laminate has a non-skin side test continuous sheet, a skin side test continuous sheet, and another continuous body, the continuous body may also be cut in the cutting step. According to this manufacturing method, the continuous body can be cut and joined together with the non-skin side test continuous sheet and the skin side test continuous sheet in the cutting step.

[0140] (3) Container According to the Embodiment Next, a container 100 according to the embodiment (hereinafter referred to as the container) will be described. Note that in the following description, components common to the above-described embodiments will be designated by the same reference numerals and will not be described again. FIG. 11 is a front view of the container 100 according to the first embodiment, and FIG. 12 is a rear view of the container 100 according to the first embodiment. The container 100 has absorbent articles 1 and a container body 101 that contains the absorbent articles. The container body 101 may be a package 100X (see FIG. 13) that individually packages the absorbent articles 1, or may contain multiple absorbent articles or packages. The container 100 of the first embodiment contains multiple packages 100X, each of which individually packages an absorbent article in a packaging sheet. FIG. 13 shows a container 100X of the second embodiment, in which packages that individually package the absorbent articles 1 constitute the container, and the packaging sheet constitutes the container body. Fig. 13(A) is a front view of the housing body 100X, and Fig. 13(B) is a front and rear view of the housing body 100X. The housing body 101 may be made of paper or a resin film. Preferably, the housing body (packaging sheet) of the housing body 100X may be made of an aluminum laminate material (PET12 / AL6 / CPP30) to suppress deterioration of the inspection member before use.

[0141] The housing body 101 has a design section 110 that is visible from the outer surface of the housing body. The design section 110 may be formed by printing, or may be formed by a sticker attached to a substrate (e.g., a resin film) that constitutes the housing body 101. The design section 110 may have an article design section 120 that depicts the absorbent article. The article design section 120 may depict at least a portion of the absorbent article, and may depict the entire absorbent article 1 or a portion of the absorbent article 1, such as a portion including the inspection member 60. The article design section 120 may have a display design section 130 that depicts the display section 62 of the inspection member 60, and a color design section 140 that depicts a colored region. A wearer visually recognizes the article design section 120 attached to the outer surface of the housing body when using, purchasing, or the like the absorbent article 1. The article design section 120 has the display design section 130 and the color design section 140. Therefore, the wearer can understand, before use, the function of the absorbent article 1 (that it has the inspection member 60) and the state of the inspection member 60 (that it is covered by the colored region R20). Because the wearer can understand the state of the inspection member 60 of the absorbent article 1 before use, when visually checking the actual absorbent article 1, it is possible to reduce the erroneous recognition that a reaction has occurred before use.

[0142] The display design section 130 may have a front display design section 131 showing the display section before coloring and a rear display design section 132 showing the display section after coloring. The rear display design section 132 may show at least the first display section 62A after coloring, and preferably show both the first display section 62A after coloring and the second display section 62B after coloring. This configuration makes it possible to show the wearer the state of the display section before coloring and the state of the display section after coloring, allowing the wearer to understand the function and usage of the inspection member and use the absorbent article with confidence.

[0143] The rear design section 130 may have a first rear design section indicating a state where an appropriate color reaction has occurred and a second rear design section indicating a state where an inappropriate color reaction has occurred. The first rear design section indicates a state where an appropriate color reaction has occurred, specifically, a state where both the first and second design sections have colored. The second rear design section indicates a state where an inappropriate color reaction has occurred, specifically, a state where the first design section has colored and the second design section has not, a state where the entire design section including the first and second design sections has colored, or a state where the center of the design section in the width direction has colored and the side sections in the width direction have not. With this configuration, the article design section can indicate appropriate and inappropriate color reactions to the wearer, allowing the wearer to understand the function and usage of the test member and use the absorbent article with confidence.

[0144] The design section 110 of the storage body 101 may have an inspection explanation section 150 including at least one of how to use the inspection member, the function of the inspection member, and how to determine the inspection results. The inspection explanation section may be in the form of text or an illustration. By having the inspection explanation section, the wearer can better understand the function and how to use the inspection member, etc., and can use the absorbent article with peace of mind.

[0145] The design unit 110 may have a pressure indicator 160. The pressure indicator 160 indicates a state in which the outer surface of the worn article S is pressed toward the wearer to bring the skin-side surface of the top sheet 11 of the absorbent article 1 into contact with the wearer's skin. As shown in FIGS. 12 and 13 , the pressure indicator 160 of this embodiment is an illustration attached to the back surface of the container 100 and the back surface of the container 100X, and indicates a state in which the wearer places their finger on the outside of the garment and presses the outer surface of the worn article toward the wearer from the garment side. By visually checking the pressure indicator 160, the wearer can understand that the outer surface of the worn article S has been pressed toward the wearer so that the skin-side surface of the top sheet 11 of the absorbent article 1 comes into contact with the wearer's skin, making it easier to perform the pressing state. By performing the pressing state, the wearer can easily guide vaginal discharge to the test member 60, and appropriate test results can be obtained based on the vaginal discharge.

[0146] The design unit 110 may include, in combination with the pressure display unit 160, an operation explanation unit 161 including at least one of an explanation of the pressing operation of pressing the outer surface of the wearable article toward the wearer and an explanation urging the wearer to perform the pressing operation. The operation explanation unit 161 allows the wearer to easily understand the pressing operation, and by performing the pressing state, the wearer can easily guide the vaginal discharge to the testing member, and appropriate test results can be obtained based on the vaginal discharge.

[0147] (4) Absorbent Article Sheet The present invention may be a sheet for absorbent articles suitable for use in absorbent articles. The absorbent article sheet allows 6% or more of an artificial body fluid having a predetermined viscosity (a viscosity of 15 to 30 Pa·s at 23°C) in contact with the skin-side surface of the absorbent article sheet to pass through to the non-skin-side surface of the absorbent article sheet. The absorbent article sheet may employ the configuration of the top sheet in the absorbent article described above. The absorbent article sheet is particularly suitable for use in absorbent articles having a test member. The absorbent article sheet of this aspect allows a high proportion of artificial body fluid having a predetermined viscosity in contact with the skin-side surface to pass through to the non-skin-side surface of the sheet, at a rate of 6% or more. Therefore, even vaginal discharge, which has a higher viscosity than urine and menstrual blood, can pass through the sheet. In particular, by using the absorbent article sheet on the skin side of the test member, a high proportion of vaginal discharge can pass through the sheet and be guided to the test member, making it possible to appropriately test the wearer's health condition from the vaginal discharge.

[0148] The absorbent article sheet and the top sheet 11 constituting the absorbent article of the above embodiment preferably do not have water-repellent properties. More specifically, the absorbent article sheet and the top sheet 11 do not need to be treated with a water-repellent treatment. The water-repellent treatment method is not particularly limited, and a wide variety of conventional methods can be adopted. Specific examples include methods using a water-repellent treatment agent such as silicone oil, fluororesin, or methylhydrogenpolysiloxane, or an oil agent containing these components. The absorbent article sheet and the top sheet 11 may be treated to be hydrophilic. The hydrophilic treatment may include, for example, a hydrophilic oil agent. If the sheet is not treated with a water-repellent treatment, it will be easier to absorb body fluids, and if the sheet is treated with a hydrophilic treatment, it will be easier to absorb body fluids.

[0149] Examples of suitable configurations for the top sheet 11 include air-through nonwoven fabrics, spunbond nonwoven fabrics, SMS nonwoven fabrics, and spunlace nonwoven fabrics. The top sheet 11 may also have apertures formed therethrough in the thickness direction. In the permeation test described below, the top sheet 11 may allow 6% or more of the artificial body fluid to permeate, preferably 10% or more, and more preferably 14% or more. A more suitable nonwoven fabric in this embodiment is one having a thickness of 0.1 mm to 0.2 mm and a fiber basis weight of 8 g / m. 2 12g / m or more 2 The following can be exemplified by spunbond nonwoven fabrics made of polypropylene fibers.

[0150] Next, a permeation test of an artificial body fluid will be described with reference to Figure 14. Figure 14 shows a schematic diagram of the test equipment used in the permeation test. The artificial body fluid used in the present invention can be corn starch (e.g., manufactured by Fuyekuni Kogyo) adjusted to a viscosity of 15 to 30 Pa s at 23°C. The test apparatus comprises a cylindrical jig 401 on which the top sheet (when measuring an absorbent article sheet, the absorbent article sheet, the same applies below) is placed, a digital force gauge (manufactured by SHIMPO (Nidec Shimpo)) 402, a force gauge stand (manufactured by SHIMPO (Nidec Shimpo)) (not shown) that supports the digital force gauge, a flat plate (acrylic plate) 404 attached to the tip 403 of the digital force gauge 402, and artificial leather (PBZ13001, IDEATEX JAPAN Co., Ltd. (Shotoku Building, 2-25-6 Taito, Taito-ku, Tokyo)) 405 attached to the surface of the flat plate 404 facing the top sheet 11. The test apparatus is set up in advance. Specifically, a filter paper 420 sized to cover the hollow portion of the cylindrical jig 401 is prepared, and the weight of the filter paper is measured. The filter paper used may be qualitative No. 2 filter paper, 100 mm x 100 mm (Advantec Toyo). Next, filter paper 420 is placed to cover the hollow portion of the jig 401 and secured to the filter paper 420. Next, the top sheet 11 is placed on top of the filter paper 420 with the skin-facing side of the top sheet 11 facing up, and the top sheet 11 is secured to the jig and filter paper. For example, both ends of the top sheet 11 are secured with cellophane tape. Furthermore, after securing a digital force gauge 402 to a force gauge stand, an acrylic plate (30 mm x 30 mm) 404 is secured to the tip 403 of the digital force gauge 402, and artificial leather (30 mm x 30 mm) 405 is secured to the acrylic plate. The top sheet 11 to be subjected to the permeation test is then prepared. The top sheet 11 is peeled off from the absorbent article, and only the top sheet 11 is removed. At this time, if the top sheet cannot be peeled off due to the adhesive, the top sheet is cooled (for example, frozen with liquid nitrogen and air-dried until the liquid nitrogen components evaporate from the removed top sheet), and then the top sheet 11 is removed. The dimensions of the top sheet are the dimensions on the cylindrical jig (equal to or greater than the dimensions of the cylindrical jig).

[0151] The permeation test begins with 0.5 mg of artificial body fluid being dropped onto the skin-facing surface of the top sheet 11. Figure 14(A) shows the state in which the artificial body fluid 410 has been dropped onto the top sheet 11 placed on a jig. The digital force gauge 402 is then lowered at 100 mm / min, and the descent of the digital force gauge is stopped when the digital force gauge in contact with the top sheet 11 indicates a value of 2.16 kPa. Figure 14(B) shows the state in which the descent of the digital force gauge has stopped. The top sheet 11 and filter paper 420 are removed from the jig, and the weight of the filter paper is measured. The weight of the filter paper after the permeation test minus the weight of the filter paper before the permeation test is the weight of the artificial body fluid that has permeated the top sheet 11. The permeation test was performed five times using five samples, and the average value was used.

[0152] Although the present invention has been described in detail using the above-described embodiments, it will be apparent to those skilled in the art that the present invention is not limited to the embodiments described herein. The present invention can be implemented in modified and altered forms without departing from the spirit and scope of the present invention as defined by the claims. Therefore, the description in this specification is intended to be illustrative and does not have any limiting meaning on the present invention.

[0153] The entire contents of Japanese Patent Application No. 2023-083679 filed on May 22, 2023, and Japanese Patent Application No. 2023-188905 filed on November 2, 2023 are incorporated herein by reference.

[0154] It is possible to provide an absorbent article that allows the wearer's health condition to be appropriately examined from vaginal discharge.

[0155] 1: Absorbent article 11: Top sheet 15: Auxiliary sheet 18: Skin-side cover sheet (second skin-side sheet) 19: Non-skin-side cover sheet (second non-skin-side sheet) 21: Back sheet 31: Absorbent core 35: Compression section 60: Test member 62: Display section 62A: First display section 62B: Second display section 64: Contact section 64Z: Sample pad 66: Transfer section 66X: Conjugate pad 66Y: Membrane 67: Absorbent section 68: Test skin-side sheet (first skin-side sheet) 69: Test non-skin-side sheet (first non-skin-side sheet) 71: First hydrophobic section 72: Second hydrophobic section 73: Third hydrophobic section 100: Container 101: Container body 110: Design section 120: Article design section 130: Display design section 131: Front display design section 132: Rear display design section 140: Colored design section 160: Pressable display section RC: Center region RS: Side region R20: Colored region R21: First colored region R22: Second colored region R25: Highly transparent region HP: Hollow section S1: Front region S2: Rear region S3: Crotch region L: Front-to-back direction T: Thickness direction T1: Skin side T2: Non-skin side W: Width direction

Claims

1. An absorbent article equipped with a test member for testing the health condition of a wearer from vaginal discharge, the absorbent article having a top sheet that is placed closer to the skin than the test member and abuts against the wearer's skin, the top sheet allowing 6% or more of an artificial body fluid that is in contact with the skin side of the top sheet and has a viscosity of 15 to 30 Pa·s at 23°C to penetrate to the non-skin side of the top sheet.

2. The absorbent article according to claim 1, wherein said top sheet, in a pressed state in which the skin-side surface of said top sheet is pressed against the wearer with a pressure of 1.60 to 1.70 kPa, allows 6% or more of the artificial body fluid that comes into contact with the skin-side surface of said top sheet to penetrate to the non-skin-side surface of said top sheet.

3. The absorbent article according to claim 2, which is an absorbent article that is attached to the inner surface of a worn article when in use, and wherein the pressed state is a state in which the outer surface of the worn article is pressed against the wearer's side so that the skin side surface of the top sheet of the absorbent article abuts against the skin side of the wearer.

4. An absorbent article according to any one of claims 1 to 3, wherein the top sheet and the inspection member are in contact with each other.

5. An absorbent article as described in any one of claims 1 to 3, wherein the width of the inspection member is shorter than the width of a woman's finger.

6. An absorbent article as described in any one of claims 1 to 3, which has a non-skin side cover sheet that covers the non-skin side of the test member, and the length of the non-skin side cover sheet in the width direction is shorter than the width of a woman's finger.

7. An absorbent article according to any one of claims 1 to 3, wherein the top sheet is constituted by a sheet having fibers, and the average inter-fiber distance of the top sheet is longer than the average diameter of a woman's pubic hair.

8. An absorbent article as described in any one of claims 1 to 3, wherein the inspection member has a contact portion that comes into contact with excrement, the contact portion and the top sheet are constituted by a sheet having fibers, and the average inter-fiber distance of the top sheet is longer than the average inter-fiber distance of the contact portion.

9. The absorbent article according to any one of claims 1 to 3, wherein the absorbent article has at least a compressed region in which a compressed portion is formed by compressing the top sheet in the thickness direction, and a non-compressed region in which the compressed portion is not formed, the inspection member has a contact portion that comes into contact with excrement, and the contact portion is in contact with the top sheet in the non-compressed region.

10. An absorbent article as described in any one of claims 1 to 3, wherein the test member has a contact portion that comes into contact with excrement and a moving portion having a labeled antibody that undergoes an antigen-antibody reaction with an excrement component that is a component contained in excrement, and the average thickness of the top sheet in the area covering the contact portion is thicker than the average thickness of the top sheet in the area covering the moving portion.

11. An absorbent article as described in any one of claims 1 to 3, wherein the test member has a center region located in the center of the width direction and side regions located on both sides of the center region in the width direction, among five equal regions obtained by dividing the test member into five equal regions in the width direction of the absorbent article, the top sheet covers the entire skin surface of the test member, and the average thickness of the top sheet in the region covering the side regions is thicker than the average thickness of the top sheet in the region covering the center region.

12. An absorbent article as described in any one of claims 1 to 3, comprising a non-skin side cover sheet covering the non-skin side of the test member, the non-skin side cover sheet being liquid impermeable and covering the entire width of the test member.

13. An absorbent article according to any one of claims 1 to 3, wherein the contact angle of the artificial body fluid with respect to the top sheet is smaller than the contact angle of the artificial body fluid with respect to the wearer's skin.

14. The absorbent article according to any one of claims 1 to 3, wherein the test member is a test member using an immunochromatography method for detecting luteinizing hormone from vaginal discharge.

15. An absorbent article container having an absorbent article as described in any one of claims 1 to 14 and a container body that contains the absorbent article, wherein the container body has a design portion that is visible from the outer surface of the container, and the design portion has a pressure indication portion that shows the state in which the outer surface of the worn article is pressed against the wearer to bring the skin side of the top sheet of the absorbent article into contact with the skin side of the wearer.

16. A sheet for absorbent articles which constitutes the skin-facing surface of an absorbent article and comes into contact with the skin-facing surface of a wearer, said sheet for absorbent articles allowing 6% or more of an artificial body fluid having a viscosity of 15 to 30 Pa·s at 23°C in contact with the skin-facing surface of said sheet for absorbent articles to penetrate to the non-skin-facing surface of said sheet for absorbent articles.

Citation Information

Patent Citations

  • Absorptive article

    JP2004073759A

  • Absorbent article

    JP2017042471A

  • Absorbent article

    JP2017176251A

  • Ink composition for moisture indicator, moisture detection sheet and method for producing the same

    JP2021130726A

  • Absorbent article

    WO2020053966A1